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Abstract
Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) are
conditions that represent significant and ongoing medical costs, including frequent
emergency department (ED) visits, hospitalizations, work absences, and disability. This
retrospective cross-sectional study, examined the effects of the frequent ED visits due to
COPD and CHF on the beneficiaries of Medicare and Medicaid in Maryland. The goal was to
identify the factors that led these patients to visit the ED, the impact of these visits on
Medicare utilization and costs across Maryland, and preventative intervention strategies to
control this population’s costs of care. Secondary data were analyzed from 2010-2012 using
the Administrative Claims Data in Chronic Condition Warehouse (CCW). The results for the
first research question revealed that an increase in the number of primary care physicians was
correlated with a decrease in ED visits; thus, persons living in areas with higher PCPs also
had lower ED visits therefore the first null hypothesis was rejected (χ2 = 3.85, p=.05) . The
results for the second research question revealed that ED visits had no significant relationship
with death in a given year; thus, patients may be diverted to less expensive care sites to
minimize cost and ED overcrowding, therefore the second null hypothesis was not rejected
(χ2 = 0, p=.98). In both cases, the confounding variables of gender, age, and race had
significant effects upon the relationship. Health Professionals and policy makers may use the
findings to develop strategies to increase supply of PCPs, adapt patient centered interventions
and modify existing chronic disease care strategies to minimize or prevent lifestyle and
environmental factors that affect chronic disease outcomes. Such improvements could
contribute to positive social change by eliminating or reducing the overcrowding that occurs
in emergency departments in Maryland and other states.
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Chapter 1: Introduction to the Study
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is associated with a significant
economic burden including frequent emergency department (ED) visits, hospitalization,
work absence, and disability (Rabe et al., 2007). COPD affects more than 24 million
adults in the United States (Gold, Phelps, Jacobson, & Neuman, 2010; Mannino, Homa,
Akinbami, Ford, & Redd, 2002) surpassing stroke as the third leading cause of death
(Center for Disease Control [CDC], 2010). COPD also affects 12% of elderly adults and
disabled Medicare beneficiaries and is frequently associated with comorbid conditions
and increased disease severity (Dalal, Shah, Lunacsek, & Hanania, 2011). In 2007, the
costs of COPD exceeded $42 billion, with $29.5 billion attributed to direct health care
expenditures and $8 billion to mortality (National Institutes of Health [NIH], 2012). One
may determine the severity of COPD and classify it by utilizing various methods.
Incidence and prevalence estimates differ greatly, depending on the methods used for
diagnosis and classification. It remains important to understand the true epidemiology of
COPD to monitor trends over time and to determine the effectiveness of potential
treatments or preventive measures (Rycroft, Heyes, Lanza, & Becker, 2012).
Similarly, Congestive Heart Failure (CHF) also represents the most common
cause of ED visits and hospitalization in the Medicare program, and led to nearly 1.4
million hospitalizations and $17 billion in total spending in 2007 alone (Medicare
Payment Advisory Commission [MPAC], 2009). Despite pharmacologic and technical
advances in the diagnosis and management of CHF, outcomes remain suboptimal: one in
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10 patients die in the first 30 days after hospitalization for CHF, and of those who
survive, one in four is readmitted (Krumholz et al., 2009). The high clinical and financial
burden of this condition, especially among elderly persons, has led to great interest in
both improving outcomes and decreasing the cost of care (Krumholz et al., 2009).
This study examined the association between COPD/CHF and the frequent ED
visits impact on utilization and costs among Maryland Medicare and Medicaid
beneficiaries. The research identified the characteristics that drive CHF/COPD patients to
frequent the ED and how they influence utilization and cost across the various counties in
Maryland. Intervention strategies were examined to help address preventive measures
and how to control cost of care for such population. This study also assessed how the
Medicare and Medicaid beneficiaries’ access their Primary Care Physicians (PCPs) as
well as the epidemiologic triad model (person, time, and place) of those with CHF/COPD
among Maryland Medicare and Medicaid beneficiaries.
This study promoted positive social change by supporting research in CHF and
COPD to assist healthcare providers in focusing more on preventive measures in reducing
CHF and COPD. The study examined how insurance coverage, access to care, cost,
location (counties), and other characteristics are related to significant differences in ED
use in the state of Maryland Medicare and Medicaid general population. Two specific
case types, CHF and COPD, were examined for the analysis, as these types were known
as costly to the medical care system (Knowlton et al., 2013).
Chapter 1 previewed this research including what the study was about along with
the related literature summaries. Applicable literature reviews were examined under
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Chapter 2. The study addressed all the specified criteria per the quantitative checklist
including research questions and hypotheses.
Background
While frequent ED use among Medicare and Medicaid beneficiaries in Maryland
is not well understood, findings from related research on other populations provide
insight that may be relevant to the Medicare and Medicaid population. In this section,
articles of frequent ED use are reviewed and relevant information will be synthesized.
Ultimately, gaps in the literature on frequent ED use will be discussed, as well as how
this research analysis will further the understanding of ED use among Medicare and
Medicaid beneficiaries in the state of Maryland. Pines et al. (2011), in a recent literature
review and expert consensus, identified several gaps in the public health and medical
literature on frequent ED use. The major challenge to coherently synthesizing results
from research conducted to date on frequent ED attendance is the lack of a meaningful
categorization of frequent users in a given year as well as longitudinally across time
(Pines et al., 2011). The authors call for a more meaningful taxonomy to describe ED
utilization based not only on frequency but also patterns such as long-term, shot-term,
and periodic use, admission to the hospital, number of facilities visited, and stratification
by specific conditions (Pines et al., 2011).
Mandelberg, Kuhn, and Kohn (2000) observed that the proportional risk of
frequent use in the elderly is not well understood, as researchers studying data based on
observations of single ED and population surveys demonstrated low representations of
older adults. The authors call for interventions focused on patients with chronic frequent
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use, as these patients may have substantial needs that are not being met in primary care
(Mandelberg et al., 2000). Gruneir, Silver, and Rochon (2011) found that lack of studies
on the effect of proactive health services, such as primary care on reducing ED visits,
represents the most obvious gap in the research literature. Fuda and Immekus (2006)
found that, in an analysis of claims from all nonfederal, acute-care hospitals in
Massachusetts, a bimodal distribution in frequent ED use is defined as five or more visits
annually with increased prevalence in patients aged 25-44 and older than 65. They
noticed that regression to the mean in frequent users with most returning in frequent or
nonuse the subsequent year (Fuda & Immekus, 2006). Cook et al.. (2004) observed
similar trend in a statewide analysis of ED claims from 1996-1998 in Utah finding that
only 5% of participants were frequent ED users in all 3 years of study. Hunt, Weber,
Showstack, Colby, and Callaham (2006) made the case that frequent ED use should be
defined according to the size and impact of the group of patients. Their rationale was that
persons accounting for a disproportionate share of ED incidents would be an appropriate
target for intervention (Hunt et al., 2006). They also emphasized that focusing on a group
that represents 25% of ED events would likely have a substantive impact on the total
number of ED visits (Hunt et al., 2006).
LaCalle and Rabin’s (2010) systematic review concluded that there is no
generally accepted standard of what constitutes frequent ED use. The identified variable
definitions ranged from two to 14 visits annually and observed that investigators usually
weigh the sensitivity of a measure in capturing the population of interest against the
specificity of defining a group that can be targeted for intervention (LaCalle & Rabin,

5
2010). LaCalle and Rabin (2010) advocated for a cut of four or more visits in a calendar
year, which is commonly used in most literatures. Locker, Baston, Mason, and Nicholl
(2007) further supported a threshold of four or more visits to classify frequent ED use.
They projected a theoretical distribution of ED visits to an ED and minor injury unit in
England. At four visits, the observed frequency plateaued at around 1000 on a
logarithmic scale, deviating significantly from the expected distribution, which continued
to decline (Locker et al., 2007). The authors found that 99.99% of chance attenders would
be expected to show up in ED less than four times in a calendar year (Locker et al.,
2007). Xu, Nelson, and Burke (2009) found that frequent ED users are heavy users of
other healthcare services; in addition, they have more outpatient visits and
hospitalizations compared to infrequent ED users.
This research contributed to the literature on frequent ED use in the state of
Maryland by examining the persistent and frequent ED use among Medicare
beneficiaries. This work identified a population of users that are potentially suited to
public health intervention. This study addressed an important gap in the current research
by exploring the importance of primary care at the community and individuals level in
reducing frequent ED use. The goal of this dissertation was to provide health services
researchers and policy makers with a better understanding of modifiable factors that
affect frequent ED use to guide future studies and inform the development of targeted
interventions and policies.
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Problem Statement
The 1986 Emergency Medical Treatment and Active Labor Act (EMTALA),
requires hospitals to perform examinations and provide stabilization treatment before
transferring a person to another provider (Byrne et al.., 2003; Centers for Medicare &
Medicaid Services [CMS], 2012). EMTALA offers hospitals no option other than treating
anyone who comes through the ED. People using ED services and increasing congestion
in emergency rooms (ERs) in Maryland hospitals has developed into a significant burden
and represents a concern to Maryland hospitals and lawmakers (Lucas et al., 2009;
Maryland Health Care Commission [MHCC], 2002). The joint work group on ED
Utilization conducted a study of ED issues (Cheung, Wiler, Lowe, & Ginde, 2012;
MHCC, 2002; Tang et al., 2010) and found that, from 1990 to 2001, ED visits rose from
1.5 million annually to 1.9 million – an increase of 27% (Garcia, Bernstein, & Bush,
2010). The group also found that hospitals increasingly use temporary closures of EDs to
manage overcrowding (Fwu, Eggers, Kimmel, Kusek, & Kerala, 2013). As a result,
ambulance diversions (as measured by hours that hospitals in the state operate on yellow
alerts status) have risen fourfold between 1996 and 2001 (Fwu et al., 2013). These
findings in utilization are consistent with the national trend (Affleck Parks, Drummond,
Rowe, & Ovens, 2013; Burt & McCaig, 2001; McCaig & Nawar, 2006).
According to LaCalle and Robin (2010); Ruger, Richter, Spitznagel, and Lewis
(2004); and Locker et al. (2007), frequent ED users are more likely to arrive by
ambulance and to be admitted to the hospital. While in the hospital, the frequent users
stay for longer periods (Locker et al., 2007). Several authors, including LaCalle and
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Robin (2010), Hunt et al. (2006), and Ruger et al. (2004), in a systemic review found that
frequent ED users are also a resource-intensive population that relies mainly on services
such as physician and hospital care.
Medicare beneficiaries are nearly twice as likely compared to privately insured
individuals to identify as frequent ED users (Hunt et al., 2006). ED uses are particularly
unhealthy events for older adults, who represent the majority of the Medicare population,
as they may start a series of adverse events such as hospitalization, readmission, nursing
homes bound, and death (Gruneir et al., 2011). Identifying individual and health system
factors associated with frequent ED users in the Medicare and Medicaid population
remained policy-relevant and would fill the knowledge gap. It would also inform and
assist Maryland policy makers in allocating scarce resources to bring about a positive
social change, such as supporting research in CHF and or COPD to assist healthcare
providers in focusing more on preventive measures in reducing CHF or COPD.
This researcher examines how insurance coverage, access to care, cost, location
(counties) and other characteristics are related to the significant differences in ED use in
the state of Maryland among the Medicare and Medicaid general population. Two
specific cases types were chosen to adjust for clinical differences among medical care
users that might bias findings. COPD and CHF were chosen as the case types for this
analysis because they are known to be costly to the medical care system (Knowlton et al.,
2013).
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Purpose of the Study
This quantitative study explored whether ED use by Medicare and Medicaid
beneficiaries in Maryland with CHF and COPD is associated with utilization and cost.
Dependent variables include two ambulatory care sensitive condition (ACSC) conditions
(e.g., CHF and COPD) and patient outcomes. Quantitative statistical analysis were used
to assess ED utilization and cost for patients with CHF/COPD compared to patients who
did not access ED during the years under consideration, while controlling for and
evaluating effects of covariates known to affect ED visits. Results were examined to
ascertain the economic burden on families, states, and the nation.
This study was unique in addressing the overcrowding in Maryland ED and the
ways Medicare and Medicaid beneficiaries with CHF and COPD influence the health
resource utilization and cost. It focused on patients 65 years and over with CHF/COPD, a
condition that need attention in the state of Maryland. The retrospective quantitative
design allowed for evaluation of the impact of ED use on acute care hospitals. The
epidemiological design study assessed hospitals ED characteristics in the counties in the
states and time of CHF/COPD condition onset.
Research Questions and Hypotheses
The primary research objective included drawing from the administrative claims
data in chronic condition warehouse (CCW) and Medicaid analytic extract files (MAX),
the researcher examined the importance of primary care, measured at the community and
individual level, in regard to episodic (1 year) and persistent (2 consecutive years)
frequent ED use in the calendar years 2011 and 2012. COPD and CHF were chosen as
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the case types for this analysis because they are known to be costly to the medical care
system (Knowlton et al., 2013).
RQ1. Is the primary care provider (PCP) supply in the State of Maryland
associated with frequent ED use among Maryland Medicare and Medicaid beneficiaries
who have either CHF or COPD?
H01: Increased ratios of PCP to State of Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD will have no significant
relationship with number of ER visits by beneficiaries, while controlling
for age, gender, and race.
Ha1: Increased ratios of PCP to State of Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD will have a significant relationship
with number of ER visits by beneficiaries, while controlling for age,
gender, and race.
RQ2. Is frequent ED use associated with end of life for Maryland Medicare and
Medicaid beneficiaries with either CHF or COPD who die during the study?
H02: Increased number of visits to the ER will not have a significant
relationship with death among Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD while controlling for age, gender,
and race.
Ha2: Increased number of visits to the ER will have a significant
relationship with death among Maryland Medicare and Medicaid
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beneficiaries with either CHF or COPD while controlling for age, gender,
and race.
Theoretical Foundation
According to Andersen’s model of health behavior, utilization of health services
is determined by chain of predisposing characteristics, enabling resources, and need
(Andersen, 2008). Need, both perceived and evaluated, represents the proximate
determinant of health services utilization (Andersen, 2008). However, predisposing
factors, such as sociodemographic characteristics and health beliefs, place certain
individuals at greater risk for developing an illness (need), and enabling resources such as
community resources and access to primary care influence the seeking of medical
services to address needs (Andersen, 2008). When need is the primary determinant of
health service utilization, rather than predisposing characteristics or enabling resources,
access to services is assumed to be equitable (Andersen, 2008). On the contrary, if
predisposing characteristics and enabling resource explain more variance in health
service utilization, it suggests inequity in utilization (Andersen, 2008) access and quality.
Andersen updated this model in 2008 to reflect the importance of contextual
characteristics as well as individual determinants of health service utilization (Andersen,
2008). Contextual characteristics can predispose (as in the demographic composition of a
community), enable (as the supply of medical personnel and facilities), or suggest need
for health services (as in mortality and morbidity rates; Andersen, 2008). These factors
interact with individual characteristics, which predispose, enable, or suggest need for
health services, as discussed in the previous paragraph. The contextual and individual

11
characteristics in turn lead to health behavior such as personal health practices (i.e.,
nutrition and fitness), processes of medical care (i.e., physician-patient communication,
ordering certain tests or prescriptions), and use of personal health services (e.g., physician
and ED visits; Andersen, 2008). Ultimately, these factors result in the outcomes of
perceived health, evaluated health, and consumer satisfaction (Andersen, 2008).
This study focused on the usage of one type of health services: ED use. The main
contextual variables of interest will be measures of insurance coverage, at two levels: (a)
the number of beneficiaries with Medicare coverage who frequent the ED and (b) the
number of beneficiaries with Medicaid coverage who frequent the ED. Other contextual
level variables such as case type, cost, sociodemographic composition and health indices
of the community will be used as controls. Individual level variables relating to
predisposing characteristics such as race, age, and Medicaid eligibility, and need (e.g.,
chronic disease diagnoses and Health Care Commission [HCC] scores) were also used as
controls to help isolate the effects of primary care factors.
The Epidemiological Triad Model is a common model used in public health
illustrates the relationships among an agent, a host, and the environment (Andersen,
2008). This, as used in communicable disease, is basic and foundational to all
epidemiology (Andersen, 2008). However, infectious diseases are no longer the leading
cause of death in industrialized nations (Andersen, 2008). As a result, a more advanced
model of the triangle of epidemiology has been developed (Andersen, 2008). The new
model includes all aspects of the communicable disease model and it is useful with the
current causes of diseases, conditions, disorders, defects, injury, and death reflecting

12
current causes of illness and conditions (Andersen, 2008). Behavior, lifestyle factors,
environmental causes, ecological elements, physical factors, and chronic diseases have
been accounted for (Lilienfeld & Lilienfeld, 1980).
Figure 1 presents an adapted and advanced model of the triangle of epidemiology,
better reflecting the behavior, lifestyle, and chronic disease issues found in modern times.
The advanced model recognizes that disease states and conditions affecting a population
are complex and that causative factors are many (Lilienfeld & Lilienfeld, 1980). It gives
recognition to the fact that many factors and elements contribute to disease in
populations.
Causetive
Factors
Factors
Time

Groups or
Populations
and Their
Characteristics

Environment
Behavior
Culture
Physiological Factors
Ecological Elements

Figure 1. Advanced model of the triangle of epidemiology. Adapted from Foundations of
Epidemiology, 2nd ed. p. 14.
Nature of the Study
This study consisted of retrospective analyses of secondary administrative claims
from the Medicare program for calendar year 2010-2012 and a corresponding 100%
Medicaid administrative claims data for the same years under consideration. A 20%
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sample of the CCW, which includes approximately 10 million Medicare beneficiaries in
any given recent calendar year, was analyzed for the study with specific emphasis on the
state of Maryland (Buccaneer, 2011). CMS (2012), in partnership with Buccaneer
Computing and Software Services, launched the CCW in 2005 as a means of linking
claims by beneficiary across the continuum of care (Buccaneer, 2011). Using a unique
beneficiary identification number, information regarding inpatient, outpatient, skilled
nursing facility, home health, hospice, and Part D prescription drug use may be linked to
demographic and assessment data for a given beneficiary (Buccaneer, 2011). The CCW
only administrates claims for beneficiaries enrolled in fee-for-service (FFS) Medicare;
encounter data for beneficiaries in Medicare Advantage (MA) managed care plans are
maintained by private health plans (Buccaneer, 2011). The MAX data, on the other hand,
is a set of person-level data files on Medicaid eligibility, service utilization, and payments
(Buccaneer, 2011). The MAX data are created to support research and policy analysis
(Buccaneer, 2011). The MAX data are extracted from the Medicaid Statistical
Information System (MSIS; Buccaneer, 2011).
Definitions
Ambulatory care sensitive condition (ACSC): Chronic diseases for which there is
wide variation in hospitalization rates and for which had better access to and quality of
primary care is believed to reduce unnecessary hospitalization (Oster & Bondmen, 2005).
Continuity of Care (COC): The period that Medicare and Medicaid beneficiaries
with CHF/COPD visited their primary care physician consistently in managing their
condition within the study period (Bayliss et al., 2015; Wolinsky et al., 2007).
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Frequent Emergency Department visit: Four or more ED visits in a calendar year
(LaCalle & Rabin, 2010).
Assumptions
The research depended on the administrative data for Medicare and Medicaid in
analyzing the impact of utilization and cost on ED visits by beneficiaries with CHF and
COPD. For the purposes of this study, it is assumed that all the beneficiaries experiencing
CHF/COPD will access ED, though it is likely that some may access other means of
heath care, which may or may not be captured in the data used.
It is assumed that an evidence of COC will help manage beneficiaries’ condition
thereby minimizing the frequent ED visits associated with CHF/COPD patients. In
general, beneficiaries who experience chronic illness may be taking prescribed
medication (Philipson, Snider, Lakdawalla, Stryckman, & Goldman, 2013). However,
this researcher anticipated that this bias might be minimized by controlling for related
covariates.
Scope and Delimitations
This study examined the Maryland Medicare and Medicaid beneficiaries (age 65
or over) with CHF and COPD conditions. Beneficiaries with these two chronic conditions
were selected for this study because they are among the leading causes of death in the
U.S. and their potential impact on ED utilization and cost are alarming (Aziz et al., 2011).
The burden of the selected conditions (CHF/COPD) on families, local governments, and
the nation merit a special attention and understanding of the characteristics that drives ED
visits and cost. Knowing these will assist health professionals and policy makers in
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controlling these public health issues through prevention measures. While there is
previous evidence of CHF and COPD interventions to minimize the impact of these two
conditions, more needs to be done with respect to prevention. In addition, CHF and
COPD are among the health conditions flagged by CMS (2012) as high-risk population
and having high readmission rate (Aziz et al., 2011; Kociol et al., 2013). Therefore, this
study focused on beneficiaries with these two diagnoses.
Other studies have focused on adults (18 years and over) because patients at any
age may experience any of the two conditions, this study included only Medicare and
Medicaid beneficiaries 65 years and over who reside in the state of Maryland. Only
beneficiaries exclusively diagnosed with CHF/COPD access the ED were considered.
While there are other subgroups suffering from the selected conditions in Maryland, it
was not feasible to include such groups.
The results of this study could potentially apply to other states within U.S. as well
as hospitals across the nation that experience overcrowding in their EDs with Medicare
and Medicaid beneficiaries afflicted with CHF and COPD. While there may be variations
between hospitals, depending on the extent of patient condition and the frequency with
which the patients access ED, geographic location of beneficiaries and other relevant
covariates were included in the study.
Limitations
CHF/COPD prevention may be encouraged through exercise, diet, and medication
or in some cases invasive surgery (Hannan et al., 2008). Nevertheless, a combination of
different approaches may be employed for a maximum outcome. An attempt was made to
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control confounding variables; however, not all covariates related to frequent ED visits
were identified. For instance, the lack of availability of an appropriate rehabilitation
environment after ED/hospital might have significantly influenced patients’ health
outcomes. Therefore, literature from previous studies was assessed to determine other
relevant variables likely to affect COC.
Design and or Methodological Weaknesses
This study attempted to produce results that may apply to other states and hospital
settings and potentially other chronic condition diagnoses (Hannan et al., 2008). Afflicted
patients with one chronic condition are generally lacking physical activities, eating
poorly, and or are sicker compared to average patients with one chronic condition
(Philipson et al., 2013). Any likely weakness were controlled for during the analyses.
Patients with congestive heart failure may have large amounts of fluid retention;
therefore, weights might have varied and some weight loss might have associated with
improvement in condition.
Biases
The biggest potential bias might have included selection bias; meaning, patients
with CHF/COPD, no Medicare, and no Medicaid benefits were not considered for this
study. CHF/COPD screening of patients in hospitals within 24 hours is a national
standard of the Joint Commission (TJC; Somanchi, Tao, & Mullin, 2011). I overcame
this bias by adjusting for CHF/COPD risk, as well as other factors affecting ED use (e.g.,
age, sex, BMI, and comorbidity score) through linear regression analysis. I understood
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the rules surrounding research and designed this study accordingly to provide the data of
interest. I believe I was free of bias in evaluating results of the study.
Significance
The significance of the study lay in the possibility of examining the significant
differences in ED use across different counties in the state of Maryland, and assessing
how insurance coverage, access to care, cost, and other characteristics related to frequent
ED use. This research could have significant implication for public health policy. As not
much is known about the characteristics of ED users in Maryland, the study could fill the
knowledge gap. In addition, it could inform and assist policy makers in allocating scarce
resources to bring about a positive social change. This research could assist policy
makers in allocating scarce resources to support research in CHF and COPD. This would
in effect assist healthcare providers to focus more on preventive measures in reducing
CHF and or COPD. Knowledge from this research could potentially assist Medicare and
Medicaid beneficiaries in making meaningful healthier lifestyle changes such as diet,
nutrition, exercise, moderation in alcohol consumption, and smoking cessation that have
the effect of prolonging longevity and minimizing the burden (healthcare cost, financial,
loss of home, single parenthood) on families and society. Ultimately, the positive effects
could alleviate the financial burden on the local, state, and federal governments. The
findings of the study could potentially suggest further reforms to improve primary care
and reduce ED utilization. Furthermore, geriatric EDs that mainly cater to the needs of
chronically ill elderly patients have recently emerged as a possible alternative to
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traditional EDs, and this research could lend support to Medicare pursuing this model of
care to cater for the most vulnerable population in our society (Hartocollis, 2012).
Summary
This chapter outlined the problem of frequent ED visits by Maryland Medicare
and Medicaid beneficiaries with CHF and COPD, and of the economic burden
experienced by families, states, and the nation as well as the need for preventive
measures and treatment of preventive strategies for patients who are Medicare and
Medicaid beneficiaries. Effective preventive measures of ED service utilization and
healthcare cost among this vulnerable population were also examined. Rosenblatt et al.
(2000) found that a PCP who is generalist, as opposed to a specialist, appears to be a
protective factor along with the patient having high COC with PCPs. Oster and Bindman
(2005) found that ambulatory care sensitive conditions (ACSC) are chronic diseases for
which there is wide variation in hospitalization rates and for which better access to and
quality of primary care is believed to reduce unnecessary hospitalization. Jencks,
Williams, and Coleman (2009) found that three ACSCs, heart failure, pneumonia, and
COPD, represented the top three causes of 30-day hospitalizations in Medicare fees for
service beneficiaries. Kirby, Dennis, Jayasinghe, and Harris (2010) reported that COPD
and CHF were two of the conditions most strongly associated with frequent readmission
on the ED use. Ruger et al. (2004) argued that gender also appears to influence ED use
with women more compared to men. They found that frequent ED users have consistently
been found to be insured and have greater odds of being covered by Medicare or
Medicaid than infrequent or nonusers (Ruger et al., 2004).
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The need for further study in understanding the characteristics of the older
population in accessing ED in managing their chronic conditions (CHF/COPD) with
respect to Maryland Medicare and Medicaid beneficiaries closed the knowledge gap and
helps reduce the economic burden as well. This study design, employed in addressing the
research, was restricted to the two chronic conditions of CHF and COPD. These two
high-risk conditions have higher health care resource utilization, costs, and high 30-day
readmission rates (Aziz et al., 2011; Kociol et al., 2013). The use of physical exercise and
diet were both studied as preventive measures. The theoretical foundation of the
epidemiological triad was discussed was to describe the problem of CHF/COPD patients’
frequent use of ED in Maryland.
Chapter 2 includes a literature review that presents further details on the research
described above. In addition, further background research on the theoretical foundation
and conceptual framework is presented in more detail in the next chapter. Chapter 3
follows, containing a description of the methods used in this study.
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Chapter 2: Literature Review
Introduction
While frequent ED use among Medicare and Medicaid beneficiaries in Maryland
is not well understood, findings from related research on other populations provide
insight that may be relevant to the Medicare and Medicaid population. Pines et al. (2011),
in a recently literature review and expert consensus, identified several gaps in the public
health and medical literature on frequent ED use. The major challenge to coherently
synthesizing results from research conducted to date on frequent ED attendance is the
lack of a meaningful categorization of frequent users in a given year as well as
longitudinally across time. The authors call for a more meaningful taxonomy to describe
ED utilization based not only on frequency but also on patterns, such as long-term, shortterm, and periodic use, admission to the hospital, number of facilities visited, and
stratification by specific conditions (Mandelberg et al., 2000). Mandelberg et al. (2000)
observed that the proportional risk of frequent use by the elderly is not well understood as
studies based on observations of single ED and population survey have low
representation of older adults. The authors call for interventions focused on patients with
chronic frequent use, as these patients may have substantial needs that are not being met
in primary care (Mandelberg et al., 2000). Gruneir et al. (2011) found that lack of studies
on the effect of proactive health services such as primary care on reducing ED visits is
the most obvious gap in the research literature.
Fuda and Immekus (2006) found that in an analysis of claims from all nonfederal,
acute-care hospitals in Massachusetts, a bimodal distribution in frequent ED use is
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defined as five or more visits annually with increased prevalence in patients aged 25-44
and older than 65. They noticed that regression to the mean in frequent users with most
returning in frequent or nonuse the subsequent year. Cook et al. (2004) observed similar
trend in a statewide analysis of ED claims from 1996-1998 in Utah finding that only 5%
of participants were frequent ED users in all 3 years of study. Hunt et al. (2006) made the
case that frequent ED use should be defined according to the size and impact of the group
of patients. Their rationale was that persons accounting for a disproportionate share of
ED incidents would be an appropriate target for intervention. They also emphasized that
focusing on a group that represents 25% of ED events would likely have a substantive
impact on the total number of ED visits (Hunt et al., 2006).
LaCalle and Rabin’s (2010) systematic review concluded that there is no
generally accepted standard of what constitutes frequent ED use. The identified variable
definitions ranged from two to 14 visits annually and observed that investigators usually
weigh the sensitivity of a measure in capturing the population of interest against the
specificity of defining a group that can be targeted for intervention (LaCalle & Rabin,
2010). LaCalle and Rabin (2010) advocated for a cut of four or more visits in a calendar
year, which is commonly used in most literatures. Locker et al. (2007) further supported a
threshold of four or more visits to classify frequent ED use. They projected a theoretical
distribution of ED visits to an ED and minor injury unit in the England (LaCalle & Rabin,
2010). At four visits, the observed frequency plateaued at around 1,000 on a logarithmic
scale, deviating significantly from the expected distribution, which continued the decline
(LaCalle & Rabin, 2010). The authors found that 99.99% of chance attenders would be
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expected to show up in ED less than four times in a calendar year (LaCalle & Rabin,
2010).
Oster and Bindman (2003) found that ACSC are chronic diseases for which there
is wide variation in hospitalization rates and for which better access to and quality of
primary care is believed to reduce unnecessary hospitalization. Jencks et al. (2009) found
that three ACSCs in particular – heart failure, pneumonia, and COPD were the top three
causes of 30-day hospitalizations in Medicare FFS beneficiaries. Kirby et al. (2010)
reported that COPD and CHF were two of the conditions most strongly associated with
frequent readmission on to the ED.
Chapter Overview
In this section, articles of frequent ED use were reviewed and relevant
information was synthesized. Ultimately, gaps in the literature on frequent ED was also
discussed, as well as how this research analysis furthered our understanding of ED use
among Medicare and Medicaid beneficiaries in the state of Maryland. This research
attempted to contribute to the literature on frequent ED use in the state of Maryland by
examining the persistent and frequent ED use among Medicare beneficiaries.
This work could help identify a population of users that are potentially suited to
public health intervention. This study could also address an important gap in the current
research by exploring the importance of primary care at the community and individuals
level in reducing frequent ED use. The goal of this dissertation was to provide health
services researchers and policy makers with a better understanding of modifiable factors

23
that affect frequent ED use in order to guide future studies and inform the development of
targeted interventions and policies.
To evaluate the problem statement for this study thoroughly, applicable previous
research literature was reviewed and summarized under Appendix A. Previous literature
identified as relevant to my research topic was used to support the study while attempting
to address potential gaps in the literature.
Literature Search Strategy
I used Google Scholar search engine, Center for Medicare and Medicaid Services
database, Walden University Database, and PubMed to identify related articles and
journals. The key words used in conducting the research include frequent emergency
department use/visits, emergency room visits, emergency department use by Medicare
and Medicaid beneficiaries in Maryland, and Medicare and Medicaid beneficiaries with
CHF and or COPD. Papers published within 6 years were mainly used for the research.
However, earlier articles that were deemed useful were also reviewed.
Theoretical Foundation
Andersen’s Model of Health Behavior
According to Andersen’s (2008) model of health behavior, utilization of health
services is determined by chain of predisposing characteristics, enabling resources, and
need. Need, both perceived and evaluated, represents the proximate determinant of health
services utilization (Andersen, 2008). However, predisposing factors, such as
sociodemographic characteristics and health beliefs, place certain individuals at greater
risk for developing an illness (i.e., need) and enabling resources, such as community
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resources and access to primary care, influence the seeking of medical services to address
needs (Andersen, 2008). When need is the primary determinant of health service
utilization, rather than predisposing characteristics or enabling resources, access to
services is assumed to be equitable (Andersen, 2008). On the contrary, if predisposing
characteristics and enabling resources explain more variance in health service utilization,
then it also suggests inequity in utilization of access and quality (Andersen, 2008).
Andersen (2008) updated this model to reflect the importance of contextual
characteristics as well as individual determinants of health service utilization. Contextual
characteristics can predispose (as in the demographic composition of a community),
enable (as the supply of medical personnel and facilities), or suggest need for health
services (as in mortality and morbidity rates; Anderson, 2008). These factors interact with
individual characteristics, which predispose, enable, or suggest need for health services,
as discussed in the previous paragraph. The contextual and individual characteristics in
turn lead to health behavior such as personal health practices (i.e., nutrition and fitness),
processes of medical care (i.e., physician-patient communication, ordering certain tests,
or prescriptions), and use of personal health services (e.g., physician and ED visits).
Ultimately, these factors result in the outcomes of perceived health, evaluated health, and
consumer satisfaction.
Andersen’s (2008) Behavioral Model (BM) has been used extensively in studies
investigating the use of health services (Babitsch, Gohl, & von Lengerke, 2012). The
studies identified for this review showed that the model has been used in several areas of
the health care system and in relation to different diseases (Babitsch et al., 2012). The
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1995 version of the BM was the version most frequently applied by researchers (Babitsch
et al., 2012). However, the studies showed substantial differences in the variables used.
The majority of the reviewed studies included age, marital status, gender/sex, education,
and ethnicity as predisposing factors and income/financial situation, health insurance, and
having a usual source of care/family doctor as enabling factors (Babitsch et al., 2012). As
need factors, most of the studies included evaluated health status and selfreported/perceived health as well as variety of diseases (Babitsch et al., 2012). Although
associations were found between the main factors examined in the studies and the
utilization of health care, there was a lack of consistency in these findings (Babitsch et
al., 2012).
This study focused on the usage of one type of health services: ED use. The main
contextual variables of interest will be measures of insurance coverage, at two levels: (a)
the number of beneficiaries with Medicare coverage who frequent the ED and (b) the
number of beneficiaries with Medicaid coverage who frequent the ED. Other contextual
level variables such as case type, cost, sociodemographic composition, and health indices
of the community were used as controls. Individual level variables relating to
predisposing characteristics such as race, age, and Medicaid eligibility, and need, such as
chronic disease diagnoses and HCC scores, were also used as controls to help isolate the
effects of primary care factors.
The Epidemiological Triad
The epidemiological triad model consists of a common model used in public
health, and it illustrates the relationships among an agent, a host, and the environment
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(Lilienfeld & Lilienfeld, 1980). This, as used in communicable disease, is basic and
foundational to all epidemiology (Lilienfeld & Lilienfeld, 1980). However, infectious
diseases are no longer the leading cause of death in industrialized nations (Lilienfeld &
Lilienfeld, 1980). As a result, a more advanced model of the triangle of epidemiology has
been developed. The new model includes all aspects of the communicable disease model
and updated with the current causes of diseases, conditions, disorders, defects, injury, and
death reflecting current causes of illness and conditions (Lilienfeld & Lilienfeld, 1980).
Behavior, lifestyle factors, environmental causes, ecological elements, physical factors,
and chronic diseases have been accounted for (Lilienfeld & Lilienfeld, 1980).
The new advanced model of the triangle of epidemiology reflects the behavior,
lifestyle, and chronic disease issues found in modern times better compared to the first
version. The advanced model recognizes that disease states and conditions affecting a
population are complex and that causative factors are many. It gives recognition to the
fact that many factors and elements contribute to disease in populations.
Applications of this Model in Ways Similar to this Study
By the 1960s, extensive studies such as the Framingham Heart Study, the Seven
Countries Study, and the British Doctors Study, began to identify the leading causes of
chronic diseases (Foody, Mendys, Liu, & Simpson, 2010). The various researches
showed the effect of cigarette smoking, poor diet, physical inactivity, and high blood
pressure to be leading causes of death (Foody et al., 2010). Almost half a century ago, the
various researches helped identified behavioral causes of chronic diseases afflicting
humankind (Foody et al., 2010). No researchers established a culprit of death to any
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particular chronic disease; instead, causes were shown to have contributed to death
(Remington & Brownson, 2010).
During and after the 1960s, researchers continued to study the relationship
between risk factors (e.g., poor diet, lack of exercise, high blood pressure) and major
chronic diseases (Remington & Brownson, 2010). For example, the diet and heart
hypothesis was tested in observational studies such as the Framingham Heart Study, a
prospective cohort study of residents of Framingham, Massachusetts (Foody et al., 2010).
At the same time, researchers shifted their focus from chronic diseases to the behavioral
risk factors preceding the diseases. The authors used the results from decades of
epidemiologic studies to explain that about half of all deaths may be attributed to few risk
factors (Foody et al., 2010). The research was later updated by Mokdad (as cited in
Remington & Brownson, 2010).
In 1974, the Canadian Lalonde Report concluded that the health of a population
could be considered in four broad elements: human biology, environment, lifestyle, and
healthcare organization (Remington & Brownson, 2010). The model of the multiple
determinants of health provides a broad conceptual framework for looking at the factors
that affect health in a society (Remington & Brownson, 2010). The multidisciplinary
approach of the model, along with other factors, were found to be accounting for
differences in health outcomes and the opportunity for prevention (Remington &
Brownson, 2010).
Some studies focused on the role of social and economic factors that had high risk
for chronic disease. Marmot’s research relating to British civil servants vividly portrayed
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these concepts (Remington & Brownson, 2010). Marmot and other researchers have since
showed demonstrated that health behaviors alone may not fully explain the risk
associated with mainly health determinants (Remington & Brownson, 2010). A new field
of social epidemiology emerged during this same period and became best known for
identifying the social rise in health, in which health outcome effects exist not only at the
extremes of high and low levels of education and income but also the ranges in between
(Berkman & Kawachi, 2000; McGinnis et al., 2002).
Previous studies have shown the contribution to health outside the environment
and behavior health (Woolf, Johnson, Phillips, & Philipsen, 2007). These factors include
socioeconomic position, race/ethnicity, social networks and support, work conditions,
economic inequality, and social capital (Woolf et al., 2007). These assertions were
summarized, stating, “The greatest advances in understanding the factors that shape
population health during the past 20 years has been the identification of social and
behavioral conditions that influence morbidity, mortality, and functioning” (Remington
& Brownson, 2010, p. 1). Though there has been a remarkable improvement in chronic
disease epidemiology and management, there is a lag between scientific knowledge of
viable chronic disease management and the widespread application to the particular
population (Remington & Brownson, 2010).
Rationale for Choice of the Theory
The proposed research focused on epidemiological dimension as opposed to
clinical trial. This retrospective cross-sectional study will use administrative data
(Medicare and Medicaid) in performing the analyses. The three confounding relating to
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the epidemiological triad model include person, time, and place. The investigative
analyses of CHF/COPD would be done by controlling for age, sex, race, and
socioeconomic factors, in relation to frequent ED use among Medicare and Medicaid
beneficiaries. The place variable that was used in the analysis of the study included the
State of Maryland, and comparing ED use in relation to CHF and COPD among
Medicare and Medicaid beneficiaries; this represented an aspect that has been shown
previously as costly (Agarwal et al., 2012). Time was considered in this study as the
duration a patient is admitted into a particular hospital and the time beneficiaries are
afflicted with CHF/COPD, whether it started in the early or later stage in the patient life
and whether the impact of ED use is affected by such timing factors.
Conceptual Framework
The CMS (2012) has been inflicting financial penalties on hospitals with high
risk-adjusted, 30-day all-cause unplanned readmission rates after an index hospitalization
for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD; DHHS,
2014). This policy is an extension of Medicare’s Hospital Readmission Reduction
Program (HRRP), which seeks to improve quality and reduce costs by creating financial
incentives for hospitals to prevent readmissions and it is a part of a trend toward
increased accountability in health care (CMS, 2012). One of the means to improve care
quality, eliminate waste, and reduce costs, performance measures is an increased use of
public reporting, pay for performance, and accreditation. All this is an effort to result in a
benefit for patients (Joint Commission, 2015).
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The focus was the topic of 30-day hospital readmissions. Among Medicare
beneficiaries discharged from the hospital in 2005, 17.6% were rehospitalized within 30
days, resulting in estimated annual expense of $17 billion (MedPAC, 2007).
Approximately 76% of these patients were rehospitalized for cause potentially due to
poor quality of care. The report hinted that decreasing avoidable, quality-driven
readmissions could possibly save $12 billion annually (MedPAC, 2007; Jencks et al.,
2009).
Literature Review Related to Key Variables and Concepts
In an effort to reduce ED visits and prevent avoidable hospitalization and
readmission as well as a means for cost savings, the U. S. Patient Protection and
Affordable Care Act (ACA) was passed in 2010. Included in this ACA was legislation to
support the HRRP, an initiative that ties Medicare reimbursement to hospitals with
patient outcomes (CMS, 2012). CMS began reducing payments by 1%, which eventually
increased to a full 3% in October 2014, to hospitals with high rates of all-cause
readmission for three conditions: acute myocardial infraction, congestive heart failure
(CHF), and pneumonia (DHHS, 2012). Until now, more than 2,000 hospitals have been
penalized nationwide, resulting in an estimated $280 million in penalties for fiscal year
2013 (Kaiser Health Network, 2012).
Since October 2014, CMS has expanded the conditions to include all-cause
unplanned readmissions after an index hospitalization for AECOPD (DHHS, 2014). In
the United States, COPD is responsible for more than 1.5 million emergency room visits
and 725,000 hospital admissions annually, with resulting healthcare costs approaching
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$60 billion (Mannino et al., 2002). Among patients hospitalized for AECOPD, 34 to 40%
do not receive recommended therapies, whereas nearly half receive at least one
inappropriate or potentially harmful therapy (Lindenauer et al., 2006; Mularski, Asch,
Shrank et al., 2006). Approximately 22.6% of patients discharged after AECOPD have an
all-cause 30-day readmission, indicating the significant impact to patients, payers, and
healthcare systems (Jencks et al., 2009; see Appendix A).
Critique of Method
Critique of CHF Studies
This section of the literature review will consist of an analysis of the various study
designs, methods, and limitations relating to the studies associated with my research.
Among the studies reviewed, there were differences in the design as well as the methods
used in analyzing the research materials. According to O’Neil et al. (2010), the results
indicated that race is a key predictor of preventable hospitalizations among the elderly for
CHF, hypertension, diabetes, and adult asthma; racial disparities in these hospitalization
rates are not explained completely by demographic and socioeconomic factors or
underlying prevalence; and the excess costs from such disparities are substantial. These
findings suggest that differences may be due to variation in access to primary care,
quality of care, and physician practice experienced by elderly African Americans
compared with Whites.
It was shown that minorities are less likely to have a regular doctor, source of
care, and medical home. They are also less likely to report getting medical care when
they need it. Further, it was found that racial disparities in access to care might be at least
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partly explained by the type and extent of medical services available within communities
with different racial compositions. The present study indirectly supports this finding, in
that overall differences were found in ACSC hospitalization rates by geographic areas
based on the racial composition of elderly residents. At the same time, it was found that
racial differences persist within geographic, that is, residence location does not explain all
racial differences suggesting that different racial groups may have different experiences
in access to and quality of care even when they have the same geographic access to care.
Biello, Rawlings, Carroll-Scott, Browne, and Ickovics (2010) found that African
Americans were hospitalized at a significantly younger ages that Whites for all causes,
chronic conditions, acute conditions, and the following conditions – uncontrolled
diabetes; bacterial pneumonia; diabetes of the circulatory system such as congestive heart
failure and hypertension; COPD; and dehydration. Some of the limitations with respect to
this study include that the data did not allow a determination of whether these were first
or repeat admissions for ambulatory care-sensitive conditions. Using discharged records
with incomplete data on SES and comorbid conditions limits the extent to which
underlying causes can be disentangled. Primary sampling units were not available in the
public-use files of the NHDS; therefore, generalized linear models could not be
performed, and robust SEs had to be performed account for the dependence of individuals
within clusters. Finally, because data were collected using discharge records, missing
data and measurement error was problematic.
On the contrary, this study had some strengths, utilizing data from a
representative national sample of more than 6800 hospital discharges. The focus on
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ambulatory care-sensitive conditions, which are frequently used measures, can be easily
replicated. Moreover, this can serve as a common metric through which changes over
time can be documented. The results of this study highlight the impact that younger age
at hospitalization may have on the social an economic well-being of individuals and their
families, through loss of wages, poorer quality of life, and risk for a greater number of
hospitalizations and severity of illness over the life span.
Another study of coronary heart disease risk trends, conducted by Kramarow,
Lubitz, Lentzner, and Gorina (2007), showed an estimated 10-year risk of coronary
events of an adult aged 45 to 65 years decreased largely despite an increased prevalence
of obesity, and diabetes. Previous discharge statistics showed ischemic heart disease
mortality and hospital admission for this population group described during the study
period. The result for younger adults was similar to the decrease among older CHF group.
The study found a 31% decrease in risk for older people aged 65 to 74 years in the study
period. Recent study evidence for the role of decreasing risk factors in reducing coronary
occurrence and mortality. The finding is similar to earlier studies of heart risk among
patients with diabetes. It also affirms reports of risk to obesity decline due to treatment of
risk factors (Ford, 2011).
Joynt, Orav, and Jha (2011) examined the relationship between volume of patients
with CHF and clinical processes, outcomes, and costs, and found that patients with CHF
discharged from hospitals with a higher volume of such patients received higher-quality
care, on average, and had better outcomes, but at modestly higher cost. These
relationships were independent of other key hospital characteristics, including teaching
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status and hospitals size. The strongest effect of volume on outcomes was seen in the
group of hospitals with the lowest volume. The effects of volume on outcomes seemed to
diminish beyond 200 to 400 discharges over the study period. The findings suggest that
the volume-outcome relationship previously observed for procedure-based conditions
also existed for CHF and may extend more broadly to chronic medical conditions. The
finding that higher volume was associated with greater inpatient costs is novel and has
important implications for the health policy debate.
Limitations to this study include lack of data about the clinicians who cared for
these patients and could not assess the effect of clinician volume or specialty on
outcomes. Additionally, because administrative data were used rather than clinical data,
the authors calculated a nurse-o-patient ratio for each hospital but lacked data on the
intensity of the nursing care that each patient received. Furthermore, administrative data
also presents difficulties in accounting for variations in the severity of illness across
hospitals. Although administrative data are imperfect, they are standardized, validated,
and increasingly used, even for public reporting. The focus on Medicare patients, though
these patients make up more than 80% of CHF admissions, the applicability of the
findings to non-Medicare patients was unclear.
Critiques of COPD Studies
The effects of exacerbations frequency of COPD patient may influence quality of
life as well as overall long-term health outcome (Laurin, Moullec, Bacon, & Lavoie,
2012). The frequency of episodes could potentially affect overall health care cost of a
state/nation. Most of the COPD studies reviewed did not touch on subgroup analysis or
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medication adherence. The researchers observed utilization, cost, and the relationship
with COPD beneficiaries with chronic bronchitis who have moderate and severe episodes
within a year regarding health care service use and cost compared to other subgroups
(Laurin et al., 2012). Patients who experience two or more episodes had higher numbers
including rate of COPD episodes, PCP visits, as well as COPD associated cost of care.
The results highlighted that severe conditions have higher utilization and costs
incurred for each patient. The amount reported under this study approximately could save
$5125 within a year for COPD patients and $11,599 total costs. These results are similar
to those reported by previous studies. For example, Yu et al. (2011) observed that health
care costs increased in parallel with the severity of exacerbations experienced by COPD
patients. Similarly, as seen in the current study, Yu et al. demonstrated that all-cause
costs were double for patients with any exacerbation compared with those without any
exacerbation. However, although similar trends in data were observed in both the study
by Yu et al. (2011) and the current study, the cost and utilization rates reported by Yu et
al. were lower compared to those observed in the current study. This may be because Yu
et al. reported the data quarterly as opposed to annually, or it may be because Yu et al.
focused on the general COPD patient rather than restricting the study to COPD patients
with chronic bronchitis. In addition, the difference in data sources and or geographic
location of the members observed in both Yu et al.’s study and the current study may
include other contributing factors to cost differences.
Interestingly, as with the study by Yu et al. (2011), the research reported in the
study derived from data from a claims database. One of the limitations inherent in using
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claims data is that clinical measures, such as FEV1, were not available to identify
baseline severity of patients or to measure outcomes during follow-up. In addition, as
with all claims data analyses, there is the possibility for error due to missing information
that was not coded in the database. However, the use of a claims database does provide a
range and depth of data not necessarily available from other resources. Importantly,
studies examining the cost of COPD exacerbations in other countries including France
Canada, and Poland (Pasquale, Sun, Song, Hartnett, & Stemkowski, 2011) reported that
cost went up because of severe exacerbations, which is similar to this research. Another
limitation was that a multivariate regression was used to account for the selection bias
and strengthen the causal inference. This design can only minimize bias affected by
covariates; it would not minimize bias caused by unmeasured covariates. Hence, no
causal deduced from the study.
Dalal et al. (2010) stated that more than 15% of hospital admission of COPD
patients in 2008 were readmitted within 30–60 days and 17.8% of ED patients had
frequent ED visit within 30 to 60 days. Other research reported that all-cause readmission
rate for COPD patients was 22.6% within 30 days and a COPD-related had 38% within 5
months (Jencks et al., 2009).
Although Dalal et al. did not assess effect of other related conditions on utilization
and cost, a number of patients afflicted with comorbidities such as cardiovascular,
depression and asthma. Having other comorbidities have the effect of high
hospitalization; for instance, asthmatic and COPD patients have significantly higher
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respiratory-related costs relating to ER visits compared to COPD alone (Blanchette,
Dalal, & Mapel, 2012).
Dalal et al. (2010) observed unadjusted relating to ER visits costs hospital
admissions. The research has advantages in that costs of treating chronic disease are
rarely examined from hospital point of view as many studies used administrative data
with third party payer. The research highlights the cost incurred by hospitals. One of the
major strength is the larger sample size pertaining to encounter categories.
A limitation affecting the larger database of inpatient data from 6022 hospitals is
that unique patients may be identified from the records from a given hospital. Those who
were readmitted to a different hospital, Dalal et al. (2010) could not evaluate the
readmission rate. Jencks et al. (2009) found that 24% of Medicare beneficiaries admitted
to a large hospital for any reason were readmitted to a different facility within 30 days.
With these limitations, rates of rehospitalization and frequent ED visits are more likely to
be underestimated.
In relation to the data, since it contained no clinical data, the authors could not
assess smoking effect. Although prominent database had all the U. S. regional
information, it mainly contained southern region data. The findings could not represent
all the regions in the U.S. Lastly, there are possible missing diagnosis codes and
procedures in administrative databases.
Yeatts et al. (2013) study conducted to estimate the burden of COPD-related ED
visits used a surveillance system that captured 99.5% of ED visits in North Carolina
provided an excellent opportunity to characterized COPD-related ED visits among a large
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population. Yeatts et al. found that the COPD-related ED visits rate of 13 per 1,000
person-years among adults 45 years and older for 2008 to 2009 was higher than a
national average of 8.72 per 1,000 person-years for 1992 to 2000 for adults greater or
equal to 25 years of age. Yeatts et al.’s estimate was similar to the 13.16 per 1,000
person-years annual rate for ages 55 to 64 years (Mannino et al., 2002), but lower
compared to the study by Rosychuk et al. (2010), which included those greater or equal
to 55 years of age (25.6/1,000). Differences between Yeatts et al. rates and previous
estimates are likely influenced by the study’s age distribution, COPD definition, and
temporal increases in disease.
Yeatts et al. (2013) related their findings to multiple ED visits were mixed
compared with previous reports in the U.S. and Canadian Eds. They found patients on
Medicare or Medicaid or noninsured patients were consistently more likely to have
subsequent 30-day, 365-day, and multiple COPD ED visits within 365 days. Although
Tsai, Griswold, Clark, and Camargo (2007) similarly found Medicaid was associated
with increased COPD ED visits, other public (all Canadian and Medicare) insurance was
not. Similar to Watson et al. (2004) that found no sex differences for ED visits.
Another study by DiBonaventura et al. (2012) examined some variables affecting
working adults 40 to 64 years suffering from COPD in the U.S. Though earlier research
evaluated impact of COPD on patient’s outcomes, few researchers have focused only on
workforce. Results indicated that workers who have COPD has significantly lower
quality of life. The study however, excluded patients under 65 years of age with COPD.
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The resource utilization was found to be significantly associated with COPD
conditions. After taking into consideration the demographic and health history variables,
COPD workers had primary care physician (PCP) visits. COPD workers showed
significantly higher ER visits and hospital admissions compared to the control group. It
may be possible that lack of PCP visits will explain patient’s productivity loss. Perhaps,
the absence of proper management of one’s condition may result in poor outcomes and
may account for higher rates of ER visits and hospital admissions (DiBonaventura et al.,
2012).
This study was a cross sectional National Health and Wellness Survey (NHWS)
so it was reported as associations rather than relationship. Due to self-reported nature of
the survey, a recall bias may have accounted for unintended errors in the observed
associations. Most could possibly be ignored to account for COPD diagnosis. Finally,
though NHWS is demographic representation of the U.S. population, the randomized
sampling framework was possibly different other than demographics, which may
influence the size and direction of the relationship observed in the study (DiBonaventura
et al., 2012).
Gap Addressed by this Study
Review of all previous literature that used administrative data and surveys were
retrospective; others however were randomized controlled studies. While the studies may
be of interest in establishing association, they may not fully exemplify the characteristics
of Medicare and Medicaid beneficiaries in Maryland with chronic conditions, specifically
CHF and COPD, and the impact on ED visits. Limited research was found regarding ED
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utilization and cost, and no literature was identified that explored the epidemiological
triad characteristics of person, time, place, and the ways some variables impact CHF and
COPD preventive measures to curb health care costs among the older population. Several
of the reviewed researchers showed a relationship between frequent ED visits and CHF
and COPD. This include the vulnerable population (Dalal et al., 2010; Pasquale et al.,
2012), patients with multiple chronic conditions (Joynt et al., 2011; Mannino et al., 2002;
O’Neil et al., 2010), and workforce (DiBonaventura et al., 2012). While these researchers
related CHF and COPD impact on ED visits to utilization and cost, none of the
researchers conducted their studies in the State of Maryland, and none considered the
epidemiological triad model’s association with the two chronic conditions.
Evidence is limited, however, on the effectiveness of intervention for patients
with a primary diagnosis of Heart failure. No studies specifically focused on Medicare
and Medicaid beneficiaries ED visits; however, studies about utilization and cost impact
among HF patients could be found. For example, the study on outpatients with CHF by
Rosychuk et al. (2010) had too small of a sample size to draw definitive conclusions.
Therefore, a gap exists for the study of CHF and COPD among Medicare and Medicaid
beneficiaries who are frequent ED users. Furthermore, no literature was identified that
observed epidemiological triad in the context of CHF/COPD. My research however will
focus on filling the gap in the previous studies is intended to help fill a gap on studies of
association of CHF and COPD patients’ utilization and cost impact in relation to frequent
ED visits will be evaluated. The epidemiological triad review will be considered in the
analysis of covariates.
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Additionally, some of the current research appears to be from outside the United
States. Several studies (Agarwal et al., 2012; Miller et al., 2006; Tan et al., 2009) took
place in Australia and New Zealand; Gershon, Wang, Wilton, Raut, and To (2010) and
Al-Hazmi et al.’s (2007) studied occurred in Canada, and Shahab, Jarvis, Britton, and
West (2006) and Soriano et al.’s (2003) studies occurred in England. Those that appear to
focus on the population in the U.S. included O’Neil et al. (2010) and Biello et al. (2010),
which were also involved in examining racial disparities in hospitalization for ACSC.
Others that related to my research focused mainly on the U.S. population in general
(DiBonaventura et al., 2012; Ford, 2011; Joynt et al., 2011; Kramarow et al., 2007;
Krumholz et al., 2009; Laurin et al., 2012; Mannino et al., 2002; Pasquale et al., 2010;
Sandoval et al., 2010; Thorpe, Ogden, & Galactionova, 2010; Tsai et al., 2007; Watson et
al., 2004; Yeatts et al., 2013; Yu et al., 2011). The other researchers who considered cost
impact included Blanchette et al. (2012); Dalal et al. (2010); Jencks et al. (2009); Marton
et al. (2006); and Miller et al.’s (2005) studies. None of the studies reviewed were
performed in Maryland, which has unique ED characteristics that has impact on
utilization and cost among Medicare and Medicaid beneficiaries, and outcomes related to
CHF and COPD interventions.
In summary, a number of factors have been identified in the existing literature that
are related to the frequent ED visits among CHF and COPD patients associated with
utilization and costs of care. CHF and COPD has been demonstrated to be a burden on
not only the families of the patients but also on the state government and the nation as a
whole. Most studies were conducted outside of the United States and none of them
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examined the epidemiological triad model. The research will examine CHF/COPD health
concerns of the most vulnerable population in Maryland, utilization and cost impact on
ED visits with consideration of person, place and time burden of the two chronic
conditions. The retrospective approach, evaluating the utilization and cost impact among
the Medicare and Medicaid beneficiaries in Maryland, and help identify whether certain
intervention strategies may help mitigate the excessive cost of care of CHF and COPD
patients, and the burden on families, and the state of Maryland.
Summary and Conclusions
As described in the above analysis, CHF represents the most common cause of
hospitalization in the Medicare program, and led to nearly 1.4 million hospitalizations
and $17 billion in total spending in 2007 alone (MPAC, 2009). Despite pharmacologic
and technical advances in the diagnosis and management of CHF, outcomes in the
suboptimal, that is, one in 10 patients dies in the first 30 days after hospitalization for
CHF, and of those who survive, one in four is readmitted (Krumholz et al., 2009). Earlier
research showed improved health among the elderly population. Though prevalence of
chronic conditions has risen, life expectancy among elderly have also increased and other
health conditions have improved (Federal Interagency Forum on Aging-Related Statistics
[FIFAS], 2010; Kramarow et al., 2007). As the trend indicates, the risk of CHD, it has
contributed to poor health, disability, and death. The consequence of the aging babyboomers could potentially put a strain on the healthcare system and cost but the overall
effect may depend on the rate and extent of CHD (Ford, 2011; Thorpe et al., 2010).
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The National health surveys showed an alarming rise of prevalence in obesity for
the past three decades, current years the rise has plateaued for women. Recently, the
prevalence of diabetes has risen for the entire population and for some age groups.
Decrease in physical activity, quality diet and risen caloric intake have been identified as
the culprit (Caballero, 2007). This has led to expectation that the negative effects on risk
outcome of the population could diminish or reverse the decrease in CHD mortality and
stroke in the future. It is interesting to note that several risk factors associated with CHD
are interrelated and show varying trend (Kramarow et al., 2007).
Similarly, treatment of exacerbation is burdensome, however, information about
cost drivers are hard to come by. COPD is known to be a leading cause of mortality and
morbidity around the globe, which affect approximately 210 million people and account
for 3 million deaths per year (World Health Organization [WHO], 2009). In the U.S.,
COPD is the third cause of death and amount to 15.4 million physician visits, 1.5 million
ED visits, and 636,000 hospital admissions annually (Mannino et al., 2002; Pasquale et
al., 2012). Referencing the national survey data, the overall economic burden of COPD in
the U.S. in 2007 yielded $42.6 billion, including $26.7 billion in health care expenditures,
while $11.3 billion was hospital care. The impact of COPD is anticipated to rise, as the
population becomes older (Dalal et al., 2010).
COPD is deemed a critical public health issue due to higher incidence and COPD
associated morbidity and mortality. The COPD condition have a significant health impact
and a significant economic burden on the nation. The COPD condition was reported for
5.1% of adults in the U.S. from 2007 to 2009, and the condition was much prevalent
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among the elderly and higher for women than men (Pasquale et al., 2012). COPD patients
ended up having one to three times exacerbation yearly and treatment usually required
ED visits or hospitalization. This posed a significant financial burden on society. Based
on target population considered, approximately 25% to 47% of COPD patients
experienced hospitalization and about 26% had emergency room visits yearly (Dalal et
al., 2010). Several observational research showed that inpatient care amounts to 52% to
70% direct medical costs of COPD (Marton et al., 2006; Miller et al., 2005).
Undoubtedly, utilization of ED services and cost increases with disease severity.
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Chapter 3: Research Method
Introduction
This retrospective cross sectional study assessed the association between
COPD/CHF and the frequent ED visits impact on utilization and costs among Maryland
Medicare and Medicaid beneficiaries. The research identified the characteristics that
drive CHF/COPD patients to frequent the ED visits and how they influences utilization
and cost across the various counties in Maryland. Intervention strategies were examined
to help address preventive measures and to control cost of care for such population. This
study also reviewed how the Medicare and Medicaid beneficiaries’ access their PCPs as
well as the epidemiologic triad model (i.e., person, time, and place) of those with
CHF/COPD conditions among Maryland Medicare and Medicaid beneficiaries.
This study promoted positive social change by supporting research in CHF and
COPD to assist healthcare providers in focusing more on preventive measures in reducing
CHF and COPD. The study examined how insurance coverage, access to care, cost,
location (counties), and other characteristic s are related to significant differences in ED
use in the state of Maryland Medicare and Medicaid general population. This section of
the dissertation proposal describes the study variables, confounders, study design,
research questions, hypotheses sampling procedure, research construct, sample size, data
analyses, and comments on threat to validity.
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Research Design and Rationale
A retrospective cross sectional study design for this research used the 2010
through 2012 Medicare Administrative Claims Data in CCW to identify individuals with
CHF and COPD, classification of Medicare-Medicaid eligibility (MME) type, and
calculation of cost and utilization statistics. Analysis was limited to individuals identified
as FFS Medicare and Medicaid due to the unavailability of managed care data in the
CCW and MMLEADS. The MMLEADS is a collection of data files of annual personlevel and service-level analytic files designed to serve as a tool for improving the care for
Medicare and Medicaid enrollees (Buccaneer, 2011). The conditions data file provides
information for the 27 CCW conditions developed to enhance research of MedicareMedicaid enrollees (Buccaneer, 2011). Integrated Medicare and Medicaid data available
in the MMLEADS from the CCW allows for research of physical conditions, eligibility,
enrollment, cost, and utilization of Medicare-Medicaid beneficiaries (Buccaneer, 2011;
ccwdata.org).
This is a retrospective cross-sectional study. The research was also designed as an
epidemiological model: person, time, and place. The observational retrospective design
allowed for evaluation of the ED utilization and the cost burden on families, states, the
nation, as well as the day-to-day operations in an acute care setting. A quantitative
method analyses was used to evaluate outcomes of Medicare and Medicaid beneficiaries
with CHF/COPD who frequent ED within the 2-year study period. This research assessed
ED utilization and the cost burden on families, states, and the nation as a whole. A
sizeable portion of the literature reviewed was prospective case-control studies. Though
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retrospective design may not have the robust internal validity of a randomized controlled
trial (RCT), it does have the advantage of greater external validity. It may also not be
generally applicable beyond the study population. The study sought to yield applicable
results that could potentially be useful to other chronic conditions other than CHF and
COPD. Furthermore, the study design has an advantage that includes predicting acute
care hospitals to inform lawmakers on healthcare cost.
Methodology
Population
Target population for this study comprised of Medicare and Medicaid
beneficiaries 65 years and older diagnosed with CHF and or COPD who are also a
frequent ED user. The study specifically focused on these beneficiaries in the state of
Maryland. Medicare and Medicaid beneficiaries who are continuously enrolled in fee-forservice (FFS) Medicare Part A and B from 2010 to 2012 were examined. Preliminary
sample of beneficiaries eligible for inclusion for this study in the CCW 100% file is
approximately 10 million, and a subsample of those with CHF and or COPD related to
the state of Maryland was extracted and analyzed.
Sampling and Sampling Procedures
Using the associated data for the specific conditions (CHF and COPD), related
ER visit and utilization de-identified data were extracted from the CCW using SPSS for
the required analysis. No informed consent was needed as the collected data has already
been cleared (Buccaneer, 2011). The ICD-9-CM’s 14,000 plus diagnosis codes and 3,900
procedure codes are aggregated into a smaller number of clinically meaningful categories
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that are easier to analyze and interpret (Elixhauser, Steiner, & Palmer, 2012). A highlevel categories of relevant chronic conditions were created based on clinical similarity
and include as dichotomous 0/1 variables in the analysis. In addition, for the analysis of
the beneficiaries with CHF and COPD, an index measure of comorbidities was created.
The CCW files internal to CMS also included hospice claims and minimum data
set (MDS) assessment data linked by the unique beneficiary ID. These files were used to
flag individuals who receive hospice care or reside in a nursing home at any point during
the study’s period. HCC scores were also be used to control for patient acuity. HCC
scores measured the predicted utilization based on a system developed by CMS for risk
adjustment in reimbursement to managed care plans (Pope et al., 2004). HCC scores were
tracked internally at CMS and were matched to beneficiaries in the CCW using the
unique beneficiary ID.
A 100% sample of the CCW, which includes approximately 10 million current
Medicare beneficiaries in any given calendar year, was analyzed for this study. CMS, in
partnership with Buccaneer Computing and Software Services, launched the CCW in
2005 as a means of linking claims by beneficiary across the continuum of care.
(Buccaneer, 2011). Using a unique beneficiary identification number, information
regarding inpatient, outpatient, skilled nursing facility, home health, hospice, and Part D
prescription drug use may be linked to demographic and assessment data for a particular
beneficiary (Buccaneer, 2011). The CCW only included administrative claims for
beneficiaries enrolled in FFS Medicare; however, encounter data for beneficiaries in MA
managed care plans are maintained by private health plans (Buccaneer, 2011).
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The study sample for the research questions consisted of Medicare beneficiaries
continuously enrolled in FFS Medicare Parts A and B from 2010-2012. Exclusion criteria
included enrollment in a MA plan, disenrollment from Medicare Part A or B, and death
during the study period. To separate ED services related to end-of-life care, beneficiaries
were excluded from the initial analysis if they died in the first 6 months of 2013. Based
on a preliminary sample creation exercise, the number of beneficiaries eligible for
inclusion for this study in the CCW 100% files was approximately 10 million. A
subsample of beneficiaries with chronic disease indicators for the ACSC of interest (CHF
and COPD) specific to state of Maryland was constructed. Finally, the beneficiaries
excluded from the initial analysis for dying between 2011 and mid 2013 were analyzed
separately and to compare ED use between those with and without hospice benefits.
Sample Size Calculations
Sample size will be extrapolated using SPSS from the 100% Medicare sample
from 2010, 2011, and 2012 data. These sample sizes were precalculated for each state
based on the available information. This study focuses on state of Maryland and as such,
the sample size was extracted from the 10 million-sample size for the Medicare Medicaid
population. Sample size analysis was conducted for each of the dependent variables as
specified by Buccaneer (2011) associated with the ED visits, as it relates to CHF and
COPD, to give a power of 80% to 95% two-sided confidence interval.
Power Analysis
I used G*Power, which is a free power analysis program, for a variety of
statistical tests in computing the sample size and the power calculation. The latest version
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3.1 presents extensions and improvements of the version introduced by Faul, Erdfelder,
Lang, and Buchner (2007) in the domain of correlation and regression analyses. The
specific model used in performing the power calculation is position regression yielding a
minimum sample size of 972 for the study, given alpha of 0.05, a statistical power of
more than 80%, and an effect size strong enough due to the potential higher anticipated
sample size for the Medicare and Medicaid beneficiaries (see Figure 2).
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Figure 2. Medicare and Medicaid beneficiaries’ analysis.
Due to the serious extreme cases of ED visits compared to others, I found the
poisson regression as an appropriate model to conduct this study. The Poisson
distribution arises when conducting a number of events across time or over an area (Faul
et al., 2007). The counts are usually represented as a rate, such as number of ED visits per
year due to CHF/COPD, or the number of ED visits per particular state (Faul et al.,
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2007). The specified region could take the form of length of time, an area, a volume, or a
period (Faul et al., 2007). It is important to note that during the analysis, logistic
regression, and Chi-Square were employed where appropriate.
Operationalization for the Variables
Measures – Independent Variables
The independent variables for the study included supply/availability of PCPs the
state of Maryland attending to the Medicare and Medicaid population; COC of the
beneficiaries; frequency of the ED visits by the beneficiaries with CHF and COPD;
season; service utilization and cost; rate of admission to the hospital, or release from the
hospital. These variables were assessed using Poison regression, Chi-Square statistics,
logistic regression, and multiple linear regression where appropriate.
At the contextual level, predisposing characteristics were measured using the
Dartmouth Atlas of Health Care (2012) and the Area Resource File (ARF). The
Dartmouth Atlas Project is an ongoing effort to document geographic variations in
medical resources and outcomes in the U.S. using Medicare data (Faul et al., 2007). The
institute provides free, downloadable reports of physician supply and other relevant
variables at the national, regional, and local level (Faul et al., 2007). Primary Care
Service Areas (PCSAs) include 6,542 small areas, defined by Dartmouth (2012), as
aggregating ZIP areas to reflect Medicare patient travel to primary care providers. PCSA
level variables occurred wherever possible. The Dartmouth Atlas contains measures for
the percent of African-Americans and percent of elderly at the PCSA level, which were
both explored as contextual level predisposing characteristics.
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The ARF, which is maintained by the Health and Resources Services
Administration (HRSA), compiles data from several sources, including the US Census
and medical professional associations to produce 6000 variables at the state level
(Healthcare Cost and Utilization Project [HCUP], 2012). The ARF describes each state as
it relates to environmental, economic, public health indicators, and healthcare resource
availability. To control for other predisposing characteristics that may influence ED use,
the percent of the population with less than a high school education, unemployment rate,
and rural/urban status was examined at the state level, consistent with previous research
(Probst, Laditka, & Laditka, 2009).
At the individual level, the Beneficiary Summary File of the CCW included
sociodemographic and clinical indicators of interest to ED use such as beneficiaries’ age
at the end of the reference year, gender, race, and chronic disease diagnoses (CHF and
COPD). The Research Triangle Institute (RTI) race code indicated racial categories
because prior research has demonstrated that it is better able to capture Hispanic ethnicity
(Frank, 2015). There was no income information in the CCW; however, the Beneficiary
Summary File did contain a variable indicating the number of months in the year that a
member was enrolled in Medicaid (Frank, 2015). Any beneficiary with at least 1 month
of Medicaid enrollment during 2010 was considered as Medicaid eligible, which was
used as a proxy for poverty status.
Measures: Dependent Variables
Congestive heart failure. Medicare and Medicaid beneficiaries with CHF must
have at least one inpatient or Part B (institutional or noninstitutional) claims with a heart
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failure code in any position during the 2-year reference period. The CCW’s chronic
condition flags require beneficiaries to satisfy both claims criteria (a minimum
number/type of claims that have the proper diagnosis of FFS Part A and B) of coverage
during the entire specified time. The CCW’s criteria were developed after reviewing
validated algorithms from the research literature and criteria used by other federal data
sources (ccwdata.org, 2015).
Chronic obstructive pulmonary disease. Medicare and Medicaid beneficiaries
with COPD must have at least one inpatient, SNF, or home health claim, or two Part B
(institutional or non-institutional) claims with a COPD code in any position during the 1year reference period. The CCW’s chronic condition flags require beneficiaries to satisfy
both claims criteria (a minimum number/type of claims that have the proper diagnosis
code and occurred within a specified time) and coverage criteria (FFS Part A and Part B
coverage during the entire specified time). This variable was also reviewed, validated,
from research literature and criteria used by other federal data sources (ccwdata.org,
2015).
Information regarding services delivered in the E.D may appear in three separate
files, as follows. Medicare beneficiaries, seen in the emergency room and admitted to the
hospital, are represented in the inpatient records; whereas, those seen in the ED, but
released, are represented in the outpatient file (Merriman & Caldwell, 2003). Additional
ED service was not captured in the inpatient and outpatient files, such as charges for
physicians not employed by a hospital and laboratory services, which were documented
in the carrier files instead (Merriman & Caldwell, 2003). Inpatient and outpatient ED

55
claims can be identified by Revenue Center Codes 0450-0459 (Merriman & Caldwell,
2003). ED claims in the Carrier files are designated by Place of Service Code 23 or
HCPCS codes 99281-99285, which represent evaluation and management (E&M) codes
for ED services (Merriman & Caldwell, 2003). Frequent ED use referred to four or more
visits in a calendar year.
Frequent users were further categorized by the persistence of frequent use over
the 2-year study period. Consistent with the rationale provided by Mandelberg et al.
(2000), beneficiaries with four or more visits in 2 or more consecutive years were
considered “persistent” frequent ED users. Beneficiaries with 1 year of frequent ED use
were considered “episodic” frequent ED users.
A further differentiation among ED users was made regarding admission to the
hospital and reason for the ED visits. Each ED visit was classified by two binary
variables for whether or not the visit resulted in a hospital admission and whether or not
the visit was for an ACSC. These determinations were based on whether the ED carrier
claim has a corresponding inpatient claim and the claim primary diagnostic code,
respectively. At the beneficiary level, this information was aggregated into a continuous
variable indicating the percentage of visits that result in hospitalization and the
percentage of visits that were for ACSC.
Medicare FFS utilization and payment data. The Medicare/Medicaid eligibility
status for all members of the study population is available in the Beneficiary/Enrollee
File. There is a single row of data for each unique person in the beneficiary fil, even if the
person was enrolled in Medicaid in more than one state during the year. The Beneficiary
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File includes detailed enrollment information, as well as descriptive information (e.g.,
demographic and summary use and payment variables).
As mentioned earlier, an adaptation with ICD-9 codes was used for this study.
The constructs in CCW to be used for this study relating to Medicare-Medicaid enrollees
has all the utilization and payments variables within the Beneficiary File. In this file,
many of useful payment and service use information has already been aggregated by
month and year for ease of use.
Data Analysis Plan
SPSS was used for the analyses. The administrative claims data that was used for
this study had already been cleaned and screened. Therefore, the claims data did not need
further scrutiny. Provider submit Medicare claims to Medicare Administrative
Contractors (MACs) for payment processing. All valid claims were uploaded to CMS
National Claims History (NCH). Then, the NCH files represented the original source data
for all CMS claims files and contained all transactional claims data. The CCW
downloaded files from the NCH and extracted the final action claims data (i.e., the final
reconciled version) to create the SPSS analytic files related to Medicare services cost and
utilization (Buccaneer, 2011). Medicare/Medicaid administrative claims data, specific to
state of Maryland beneficiaries with either CHF or COPD who frequent ED, was tested
against the following research questions and hypotheses:
RQ1. Is the primary care provider (PCP) supply in the State of Maryland
associated with frequent ED use among Maryland Medicare and Medicaid beneficiaries
who have either CHF or COPD?
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H01: Increased ratios of PCP to State of Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD will have no significant
relationship with number of ER visits by beneficiaries, while controlling
for age, gender, and race.
HA1: Increased ratios of PCP to State of Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD will have a significant relationship
with number of ER visits by beneficiaries, while controlling for age,
gender, and race.
RQ2. Is frequent ED use associated with end of life for Maryland Medicare and
Medicaid beneficiaries with either CHF or COPD who die during the study?
H02: Increased number of visits to the ER will not have a significant
relationship with death among Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD while controlling for age, gender,
and race.
HA2: Increased number of visits to the ER will have a significant
relationship with death among Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD while controlling for age, gender,
and race.
Description of Data Analysis Plan
An exploratory data analysis was used to examine the distribution of ED visits as
a count outcome and as a categorical outcome. Histograms displayed the frequency of ED
counts from zero to the highest count, and bar graphs will display the distribution of
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Medicare beneficiaries among the four ED categories of non-, infrequent, and episodic
frequent and persistent frequent users. A descriptive correlational design explored
comparisons among the four categories of ED users using chi-squared statistics for
categorical variables and multiple linear regression for continuous variables. Tables were
created to display the relative values of the variables along with p-values to indicate
statistical significance. Relevant comparisons among the four ED categories will include:


Mean age, percent over 65 and under 65



Percent Medicare/Medicaid eligible



Mean primary care physician supply/1,000, percent high, medium and low
supply



Percentage of visits resulting in hospitalization



Percentage of visits for ACSC (CHF and COPD)

The research analysis also included a series of univariate multinomial logistic
regression models to test univariate relationships between the categorical outcome of ED
use and the independent variables. All independent variables, with a statistically
significant association with ED use, were included in a multivariate multinomial model.
Finally, multivariate multinomial logistic regression was used to determine the
relative risk ratio of being an infrequent, episodic frequent, and persistent frequent ED
user compared to a non-user. The multinomial logistic regression model was an extension
of the simple logistic regression model for dichotomous dependent variables that applies
to discrete, nominal, and unordered poltytomous dependent variables (Kwak & ClaytonMatthews, 2002). Unlike ordinal logistic regression models, multinomial models do not
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assume proportional odds for being in each category higher than the base category and
instead estimate separate equations for each category compared to the base category
(Weng & Barner, 2005). As in the case of the simple logistic regression, maximum
likelihood estimation (MLE) is used as the normality assumption of ordinary least
squared (OLS) regression is violated (Weng & Barner, 2005). Wald tests were used to
test the significance of regression coefficients (Kwak & Clayton-Matthews, 2002).
One assumption of multinomial logistic regression models is that the error terms
are independent across individuals and equations. Another key assumption is that of the
Independence of Irrelevant Alternatives (IIA), which posited that the inclusion or
exclusion of one category should not affect the relative odds of any other category. To
test this assumption, I performed a Hausmann test, which compared the estimated
coefficients of the unconstrained model with all dependent categories to the estimated
coefficients of various constrained models that exclude one category. If the results did not
support IIA, I would have used a probit model that allows for flexibility in this
assumption. Results were reported in terms of relative risk ratios for being in each
category compared to the index category of no ED use.
Threats to Validity
Threats to External Validity
There are several advantages in using the administrative claims data in CCW,
including that the results from this study were applicable to the majority of elderly men
and women in America. There were some limitations to working with the CCW. First, it
only represented fee-for-service Medicare enrollees, thus one cannot draw conclusions
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about beneficiaries in MA plans (Buccaneer, 2011). However, only 20% of Medicare
enrollees were in MA plans in 2010, thus CCW still captured the vast majority of the
Medicare population (Global Initiative for Chronic Obstructive Pulmonary Disease
[GOLD], 2010). Therefore, the conclusions I drew remained generalizable to
beneficiaries enrolled in traditional Medicare, and the study still had strong external
validity.
Threats to Internal Validity
One major threat to internal validity of my approach to studying frequent ED use
includes that using administrative claims data precluded examination of critical aspects of
access to care and quality of care, including clinical measures, such as blood pressure,
measures of patient functioning, or patient-provider communication. For instance, I could
not gauge care coordination among medical providers, which obviously represented an
important aspect of managing ACSCs. Without self-reported information from patients
and providers, I could not explore certain factors that might be relevant to predicting ED
use, such as ease of getting an appointment with a primary care provider and satisfaction
with primary care providers.
Threats to Construct or Statistical Conclusion Validity
To avoid threats to statistical conclusion validity, I studied frequent ED use over a
longer period, specifically 2 years. This allowed for a more definitive and practical
classification of users by persistence of use and concentration of ED use within a given
year. Due to the large sample size of the Medicare and Medicaid population, there was no
threat to the statistical power resulting larger sample is not identified.
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Another threat to validity may occur if statistical analyses are performed outside
the framework of the statistical test, for instance, abnormality of error distribution or
nonlinear relational linear regression. For the purpose of this study, all appropriate
assumptions tied to the frequent ED use in the CCW administrative data were applied to
avoid invalidity of statistical conclusion. Correspondingly, using two case studies (CHF
and COPD) helped reduce any threat to validity. It is important to note that the CMS
administrative claims data in CCW have been thoroughly cleaned and vetted for research
purposes (Buccaneer, 2011) to prevent any distortions in the CCW data.
Ethical Procedures
This study went through the approval process of the Walden University
Institutional Review Board (IRB) paving the way for data collection and analyses of the
study. With respect to using the CCW in accessing the Medicare Administrative data, I
already had access in using the data as an employee for research purposes, and I did not
anticipate any issues in conducting the research and performing any related analyses.
Prior to this, I was cleared and certified for CMS’ privacy and HIPAA regulations. I
followed all HIPAA regulations governing the use of the Medicare Medicaid Claims
data. If any ethical questions arose, I intended to consult with the school IRB and the
agency ethics committee as needed.
Summary
In summary, this retrospective study with quantitative analysis of the relationship
between Medicare population with chronic CHF and COPD and frequent ED visits. The
impact on ED utilization and cost was examined to ascertain the burden on families,
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hospitals, and the state of Maryland. I analyzed using linear regression, and two tailed ttests to examine the distribution of ED visits. A descriptive correlational design was
compared among the four categories of ED users using chi-squared statistics for
categorical variables. Charts and tables were created to illustrate the relative values of the
variables in conjunction with p-values to show statistical significance of this study.
Including variables relevant to place, time, and place would render the epidemiological
analyses as an effective approach to care and wellbeing of Medicare and Medicaid
beneficiaries with diagnosis of heart failure and congestive obstructive pulmonary
disease. Data collection, analysis, and results of this study were provided in the following
chapter.
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Chapter 4: Results
Introduction
The purpose of this study is to examine key characteristics of frequent ED visits
and used administrative claims data to assess utilization and cost for Medicare and
Medicaid enrollees that were identified as having either CHF or COPD. This was done
using ICD 9 Codes – primary and secondary diagnostic code (see Appendix 1).
Specifically, administrative claims data for the State of Maryland was used, focusing on
beneficiaries with either CHF or COPD who visited ER in the years 2010, 2011 and
2012.
This chapter will first present data cleaning and preprocessing, then summary
statistics of the data. Next, data analysis using GEE’s will be presented to answer both of
the research questions and the results discussed. Finally, a summary will conclude the
chapter.
Data Cleaning and Preprocessing
The initial sample size was 33,174. Some subjects changed age, gender and race
through the years. It was assumed that the age, gender and race reported in 2010 was the
correct age, gender and race for data analysis purposes and all other demographic data
was removed from the analysis. There was also significant amounts of missing data
regarding if a patient had made an ER claim, visited the ER or payment was made that
year. This missing data was assumed to be 0 throughout. Finally some patients had
missing age, race or dead status data. These patients were removed from analysis. This
left a dataset of 14,118 for analysis. Finally, to ensure continuity of dead status, data from
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patients that have died was removed from the following years. 1,335 subjects died during
2010 and their data was removed from subsequent years and an additional 1,085 subjects
died in 2011 and their data was removed from 2012. All data cleaning was conducted in
R 3.1.2.
Data Analysis
Summary statistics of continuous variables are presented in Table 1. The average
age of subjects included in the study was 79.63, and the average number of ER visits for
2010, 2011 and 2012 were 1.52, 1.46 and 1.50 respectively.
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Table 1.
Summary Statistics of Age, ER Visits, ER Claims and Payments for the years 2010, 2011
and 2012 for all COPD and CHF patients.
Variable
Age

ER Visits

ER Claims

Payment
Amounts

Statistics
Mean
Minimum
Maximum
Standard
Deviation
Mean
Minimum
Maximum
Standard
Deviation
Total Visits
Mean
Minimum
Maximum
Standard
Deviation
Mean

2010
79.63
65
110
8.84

2011
-

2012
-

1.52
1
20
0.43

1.46
1
11
0.35

1.50
1
12
0.37

2332
0.10
0
20
0.35

1797
0.08
0
11
0.00

1551
0.07
0
12
0.00

193.85

182.42

189.49

Minimum
Maximum
Standard
Deviation
Total Claims ($)

0.00
2565.33
6921.74

0.00
1264.86
5862.90

0.00
1560.21
4194.59

297954.50

224924.00

196319.00

Summary statistics of categorical variables are presented in Table 2. Most
subjects were female (70.8%) and white (46.6%). The death rates for 2010, 2011 and
2012 were 9.50%, 7.78% and 12.00% respectively. Many racial categories had only a few
subjects in each, so for the purposes of analysis they were combined into White (n =
6573), Black (n = 5240) and Other (n = 2305) which included all other racial categories
including unknowns. Many subjects had both COPD and CHF, subjects with both
generally formed just over one third of the sample.
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Table 2.
Summary Statistics of Gender, Race and Death for 2010, 2011 and 2012 for all COPD
and CHF patients.

Variable Level
Gender Male
Female
Total
Age
Under 70
71-89
Over 90
Total
Race
White
Black
Other
Total
Died
No
Yes
Total
Admitted to
Hospital
Disease COPD
CHF
Both
Total

2010
Count
4118
10000
14118
2871
9135
2112
14118
6573
5240
2305
14118
12783
1335
14118
753

2011
Percentage Count
29.2
70.8
100.0
20.3
64.7
15.0
100.0
46.6
37.1
16.3
100.0
90.50
11698
9.50
1085
100.0
12783
717

2012
Percentage Count
92.22
10294
7.78
1404
100.0
11698
798

Percentage
88.00
12.00
100.0
-

3034
6064
5020
14118

21.5
42.9
35.6
100.0

20.1
41.0
38.7
100.0

19.0
38.6
42.3
100.0

2578
5248
4957
12783

2225
4521
4952
11698

Research Question 1.
Research Question 1 asked: Is the primary care provider (PCP) supply in the State
of Maryland associated with frequent ED use among Maryland Medicare and Medicaid
beneficiaries who have either CHF or COPD?
H01: Increased ratios of PCP to State of Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD will have no significant relationship with number
of ER visits by beneficiaries, while controlling for age, gender and race.
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HA1: Increased ratios of PCP to State of Maryland Medicare and Medicaid
beneficiaries with either CHF or COPD will have a significant relationship with number
of ER visits by beneficiaries, while controlling for age, gender and race.
The total number of PCP providers (see Appendix 2) in Maryland was 5,622,987
for 2010, 5,699,640 for 2011 and 5,701,628 for 2012. PCP was converted to number of
providers per CHF or COPD patient (33,174 from unreduced dataset), giving 169.49 PCP
per CHF or COPD patient for 2010, 171.81 for 2011 and 171.87 for 2012. It should be
noted that these definitions did not include nurse practitioners, physician’s assistants and
online/telehealth professionals which could affect the outcomes of this analysis.
Summary data on the number of ER visits for each independent variable is
presented in Table 3. On average, males had more ER visits (7 per 100 individuals) in a
given year than females (6 per 100 individuals) and subjects who identify as white also
have the highest average of ER visits (7 per 100 individuals) in a given year for any racial
category. Under 70’s also had the highest average of ER visits out of any age category
(10 per 100 individuals), and finally 2010 which had the lowest ratio of PCP to CHF and
COPD patients had the highest average number of ER visits (8 per 100 individuals).
There were no obvious differences in mean number of ER visits for patients with and
without CHF and COPD, although subjects without COPD had the highest mean ER
visits (9 per 100 compared to 8 per 100 for all other COPD and CHF categories).
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Table 3.
Summary Statistics for ER Visits for each Independent Variable.
Independent Variable

Level

Gender

Male
Female
White
Black
Other
Under 70
71-89
Over 90
169.49 (2010)
171.81 (2011)
171.87 (2012)
No
Yes
No
Yes

Race

Age

PCP Ratio

CHF
COPD

Mean ER Visits per
100
7
6
7
6
5
10
6
5
8
6
6
8
8
9
8

Std Deviation ER Visits
per 100
44.7
36.6
41.1
37.9
35.4
49.2
36.8
34.1
43.1
35.8
37.0
38.6
43.9
46.3
40.0

This research questions was answered using a Generalized Estimating Equation
with Poisson log-linear distribution and robust variance estimates (Williams 2000) to
account for repeated measurements by subject through the years. A model was fitted that
included ER visit count as the dependent variable, total number of PCP providers as the
independent variable and that included age, race, gender and COPD or CHF status as
confounding variables. The model that was developed included separate parameters for
COPD status and CHF status. This type of model assumes that the effect of COPD and
CHF on number of ER visits is additive when a subject has both. A correlation matrix
with an exchangeable structure was used. Type I tests for model effects using Wald ChiSquare tests (Deddens et al. 1998) are presented for the model in Table 4. Based on the
significant effect of PCP ratio on number of ER visits, we accept the alternative
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hypothesis and also conclude that the confounding variables of gender, age, race and
COPD status are significant. To determine the strength of the effect, the model
parameters were examined.
Table 4.
Significance of Variables for Research Question 1.
Variable
Intercept
PCP Ratio
Gender
Age (categorical)
Race (categorical)
CHF
COPD

Wald Chi Square
5705.59
6.076
5.499
52.85
6.802
1.522
3.850

df
1
1
1
2
2
1
1

P value
< 0.001
0.01
0.02
< 0.001
0.03
0.22
0.05

The model developed to answer question 1 has the following formula:
Vij ~ Poisson (Yij)
Log(Yij) = β0 + β1 gi + β2 xi + β3 zi + β4 pj + β5wi + β6bi + β7hi + β8ci + εij
where Vij is the number of visits for subject i at year j is Vij, gi is equal to 1 if
subject i is male, 0 otherwise, pj is the ratio of primary care providers for year j, xi is
equal to 1 if the subject is aged 70 or under, 0 otherwise, zi is equal to 1 if the subject is
aged between 71 and 89, 0 otherwise, wj is equal to 1 if the subject is white, 0 otherwise,
and bj is equal to 1 if the subject is black, 0 otherwise. hi is equal to 1 is the subject does
not have CHF and ci is equal to 1 if the subject does not have COPD, 0 otherwise for
both. εij is the error term for subject i in year j. Parameter estimates, standard errors and
significance are presented in Table 5.
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PCP ratio was found to have a significant relationship with number of ER visits,
where an increase of PCP ratio by 1 increases ER visits by 3%. The confounding
variables of gender, age race and COPD status were also found to have a significant
relationship with number of ER visits. Being male increased the number of ER visits by
9% compared to being female, and not having COPD increases ER visits by 11%
compared to having COPD. Being aged below 70 increased ER visits by .76 compared to
being aged over 90, and being aged between 71-89 increased ER visits by .10 compared
to being aged over 90. Finally, being white increased ER visits by .29 compared to being
in the ‘other’ racial category, and being black increased ER visits by .25 compared to
being in the ‘other’ racial category.
Table 5.
Parameter Estimates.
Parameter
Intercept (β0)
PCP Ratio (β4)
Gender = Male (β1)
Gender = Female
Age below 70 (β2)
Age between 71-89 (β3)
Age above 90
Race White (β5)
Race Black (β6)
Race Other
Does not have CHF (β7)
Has CHF
Does not have COPD (β8)
Has COPD

β
-9.487
0.03
0.09

Std Error
3.24
0.01
0.07

E^ β
0.00
1.03
1.09

0.57
0.10

0.11
0.10

1.76
1.10

0.26
0.23

0.10
0.10

1.29
1.25

-0.006

0.06

0.99

0.11

0.05

1.11

Wald Stat
8.589
4.019
1.899
Baseline
24.486
1.046
Baseline
6.396
5.206
Baseline
0.010
Baseline
3.850
Baseline

Df
1
1
1

P value
0.003
0.04
0.17

1
1

< 0.001
0.03

1
1

0.01
0.02

1

0.92

1

0.05
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Research Question 2
Research Question 2 asked: Is frequent ED use associated with end of life for
Maryland Medicare and Medicaid beneficiaries with either CHF or COPD who die
during the study?
H02: Increased number of visits to the ER will not have a significant relationship
with death among Maryland Medicare and Medicaid beneficiaries with either CHF or
COPD while controlling for age, gender and race.
HA2: Increased number of visits to the ER will have a significant relationship with
death among Maryland Medicare and Medicaid beneficiaries with either CHF or COPD
while controlling for age, gender and race.
Summary statistics of deaths for each categorical variable are presented in Table
6. The large total counts are due to each subject having repeated measurements over 3
years, hence totals are three times larger than those presented in Tables 1 and 2. Males
and females had comparable death frequencies (11.1% for each), but subjects who
identified as white had a higher frequency of deaths than other racial categories (12.6%).
Subjects who were aged under 70 had the lowest frequency of death out of all the age
categories (7.0%). Death rates for subjects with and without CHF were similar (10.0%
and 9.7% respectively), and death rates for subjects with and without COPD were also
similar (10.0% and 9.9% respectively).
The mean number of ER visits for subjects who did not die was 0.07 (standard
deviation = 0.39) and the mean number of ER visits for subjects who did die was 0.06
(standard deviation = 0.40).
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Table 6.
Summary Statistics for Death for each of the Categorical Independent Variables.
Independent
Variable
Gender
Race

Age

CHF
COPD

Level
Male
Female
White
Black
Other
Under 70
71-89
Over 90
No
Yes
No
Yes

Died
(Count)
2258
5621
4186
2763
930
948
5229
1702
913
3477
1869
2521

Died
%
11.1
11.1
12.6
10.4
8.4
7.0
11.2
16.2
9.7
10.0
9.9
10.0

Not Dead
(Count)
18126
44745
26122
23654
10095
12549
41537
8785
8437
31104
16976
22565

Not Dead
%
88.9
88.9
87.4
89.5
91.6
93.0
88.8
83.7
90.2
89.9
90.0
89.9

Total
20384
50366
33308
26417
11025
13497
46766
10487
9350
34581
18845
25086

This time a GEE with a binary logistic distribution and robust variance estimates
was estimated to predict death using ER visits and the confounding variables of age,
gender, race and COPD and CHF status were included. Similar to the previous model,
separate parameters were used for both COPD and CHF status, which assumes the effect
of both on death outcome is additive. A correlation matrix with an exchangeable structure
was used. Type I tests for the second model are presented in Table 7. Based on these
findings we accept that ER visits had no significant relationship with death in a given
year, therefore we accept the null hypothesis. The confounding variables of age and race
were both found to be significant. To estimate the effect of these variables on death, the
model parameters were examined.
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Table 7.
Significance of Variables Included in the Model for Research Question 2.
Variable
Intercept
Gender
Age (categorical)
Race (categorical)
CHF
COPD
ER Visits

Wald Chi Square
16087.04
2.22
339.05
120.19
0.327
0.646
0.000

df
1
1
2
2
1
1
1

P value
< 0.001
0.13
< 0.001
< 0.001
0.56
0.42
0.98

This model has the following formula:
Dij ~ Bernoulli(Yij)
Log(Yij/1- Yij) = β0 + β1 gi + β2 xi + β3 zi + β4 vij + β5wi + β6bi + β7hi + β8ci + εij
where Dij is the death outcome of subject i in year j, gi is equal to 1 if subject i is
male, 0 otherwise, vij is the number of ER visits for subject i in year j, xi is equal to 1 if
the subject is aged 70 or under, 0 otherwise, zi is equal to 1 if the subject is aged between
71 and 89, 0 otherwise, wj is equal to 1 if the subject is white, 0 otherwise, and bj is equal
to 1 if the subject is black, 0 otherwise. hi is equal to 1 is the subject does not have CHF
and ci is equal to 1 if the subject does not have COPD, 0 otherwise for both. εij is the error
term for subject i in year j. Parameter estimates for this model are presented in Table 8.
The two variables found to be significant were age and race. Being aged 70 and
below was found to decrease the odds of death by .65 compared to being aged over 90.
Being aged between 71 and 89 was found to decrease the odds of death by .35 compared
to being aged over 90. Being white was found to increase the odds of death by .68
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compared to being in the ‘other racial category. Finally, being black was found to
increase the odds of death by .47 compared to being in the ‘other’ racial category.
Table 8.
Parameter Estimates.
Parameter
Intercept (β0)
ER Visits (β0)
Gender = Male (β0)
Gender = Female
Age 70 and below (β0)
Age between 71-89 (β0)
Age above 90
Race White (β0)
Race Black (β0)
Race Other
Does not have CHF (β0)
Has CHF
Does not have COPD
(β0)
Has COPD

Β
-2.09
-0.001
0.06

Std Error
0.06
0.04
0.03

E^β
0.12
0.99
1.06

Wald Stat
1269.79
0.00
3.77

df
1
1
1

P value
< 0.001
0.98
0.05

-1.03
-0.42

0.06
0.04

0.35
0.65

334.09
105.75

1
1

< 0.001
< 0.001

0.52
0.39

0.05
0.05

1.68
1.47

119.48
61.66

1
1

< 0.001
< 0.001

-0.03

0.04

0.97

0.76

1

0.38

-0.03

0.03

0.97

0.645

1

0.42

Summary
The purpose of this study was to determine what variables contributed to
increased ER visits and death among Medicaid and Medicare beneficiaries whom are
identified with CHF or COPD in the state of Maryland, using a sample from the
MMLEADS in the years 2010, 2011 and 2012. This was done using two GEE type
regression equations to determine which variables such as age, gender, PCP availability
and race significantly affect either ER visits or death outcome for a given year. Increased
PCP was found to significantly decrease the number of ER visits when controlling for
other confounding variables. Alternatively, persons living in areas with higher PCP also
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had lower ER visits. It is likely that the classification of PCP categories could affect this
finding, and future studies may need to use a broader definition of a primary care
provider. There was no significant relationship found between the number of ER visits
and death outcome in a given year. The broader implications of these results will be
discussed in chapter 5.

76
Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
Medicare and Medicaid recipients across the country aged 65 and older are a
resource intensive population for which CHF and COPD are an ongoing issue (Dalal,
Shah, Lunacsek, & Hanania, 2011; MPAC, 2009). In Maryland, ED visits are on the rise,
and between 1990 and 2001, ER visits increased from 1.5 million to 1.9 million across
the United States (Aziz et al., 2011; Garcia et al., 2010; Kociol et al., 2013; Lucas et al.,
2009). Because of these increases, hospital administration decided to use temporary
closings as a cost cutting measure, a decision that influenced ambulatory services through
increased utilization (Fwu et al., 2013). The designation of resource intensive clientele
refers to frequent ED users, as they are more likely to arrive by ambulance and receive a
bed within the hospital for services (LaCalle & Rabin, 2010; Locker et al., 2007; Ruger et
al. 2004).
Most in American society are unwilling to pay the costs associated with caring for
frequent ED users, who are likely to be, according to research, poor, male, socially
isolated, chronically, and psychologically ill alcoholics (Mandelberg, Kuhn, & Kohn,
2000). Thus, the impetus is to find a way to lower costs without closing ERs; therefore,
this study was both relevant and necessary.
The current quantitative study was a retrospective cross sectional study designed
to explore the connection between Maryland Medicare and Medicaid beneficiaries with
CHF and COPD and frequent emergency room use and cost. It was conducted both to
evaluate the impact of ED usage on patients from the aforementioned demographic, and
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to add to the current research on ways to lower costs to Maryland hospitals through
preventive services designed to reduce ED utilization (Burt & McCaig 2001).
This chapter will discuss and interpret the findings of the study and point to the
potential implications of the study findings on hospital EDs across the United States. In
addition, the chapter will conclude with recommendations for further research.
Discussion
The primary research objective was to examine the importance of primary care
provider usage for Medicare and Medicaid patients with CHF or COPD, at the
community and individual levels, as they relate to episodic, persistent, and frequent ED
usage during the calendar years of 2010 and 2012. Secondarily, the research sought to
determine if frequent visits to the ED were associated with end of life for the same
population in those same years.
Two research questions informed the research in this study:
1.

Is the PCP supply in the State of Maryland associated with frequent ED
use among Maryland Medicare and Medicaid beneficiaries who have CHF
or COPD?

2.

Is frequent ED use associated with end of life for Maryland Medicare and
Medicaid beneficiaries with either CHF or COPD who die during the
study?

I used the study to either confirm or deny the association through the collection
and analysis of data, or alternately, that there was a definite connection between the two
phenomena studied within each question.
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Interpretations of the Findings
Hypothesis 1 and 1a
The presumption (Hypothesis 1) was that either there would be no significant
difference in the number of ER visits for any gender, race, or age of Medicare or
Medicaid beneficiaries as a result of an increase in PCPs, or alternately, (Hypothesis 1a),
that there would be a significant difference due to the increase. Tests of the data collected
determined that the year with the lowest number of PCPs included 2010, which coincided
with the highest number of emergency room visits by patients with CHF and COPD, thus
proving the first supposition to be true.
The measure of the probability that the researcher’s assumptions are correct (its pvalue) was calculated to determine the presence or absence of statistical errors in the data.
A p-value that is calculated to be less than or equal to 0.05 indicates that the first
presumption (Hypothesis 1) was not acceptable, and that the researcher must then accept
the alternative assumption (Hypothesis 1a). In this case, the data indicating the rate of the
yearly PCP increase, gender, and age, all have p-values of less than 0.05, thus the first
presumption, that there would be no difference in the rate of ER usage relative to age, and
gender, was rejected, proving that there was indeed a relationship between these
variables.
The analysis of p-value also revealed that gender played a significant part, as rates
of ER visits for males were higher compared to those for females, increasing slightly
during each year studied. Additionally, patient age was also positively correlated. Perhaps
surprisingly, being aged 71 to 89 was negatively related to ER visit frequency, with the
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number of visits decreasing, instead of increasing as alternate hypothesis suggested, each
year when compared with the number of visits for patients aged 70 years or less.
Remarkably, for patients over the age of 90, ER visits also decreased a small percentage
annually as compared with those of patients 70 and younger.
Because it showed a higher p-value, the variable of race was not statistically
significant enough to reject the null hypothesis in research question one. The p-values for
data relative to race were larger, with a p-value of .09, indicating that the researcher could
not reject Hypothesis 1. Thus, for age and gender only, the alternate hypothesis
(Hypothesis 1a), which stated that there would be a significant difference in ER usage
due to the increase in PCP’s was affirmed.
Hypothesis 2 and 2a
Another research question posed in this study indicated the extent to which
frequent use of the ED was associated with end of life for Medicare and Medicaid
beneficiaries with CFH or COPD with regard to age, race, and gender. The presumption
was that increased emergency room visits would not influence death rates (Hypothesis 2),
while the alternate view (Hypothesis 2a) suggested that it would. Results of the data
analysis showed that frequency of ER visits had no significant impact on end of life for
Medicare or Medicaid beneficiaries with COPD or CHF concerning gender as the p-value
was calculated to be 0.89, much higher than the .05 necessary to reject the Hypothesis 2.
Race and age however, proved to be significant due to p-values that were less than .001,
showing that Whites and patients under the age of 70 had higher rates of death than those
from other racial and age groups relative to frequency of ER visitation. Interestingly,
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patients under the age of 70 were the least likely of all age categories to die, regardless of
ER visit frequency.
The current study explored the correlation between ER visits and death among
Medicaid and Medicare beneficiaries in Maryland identified to have CHF or COPD. The
researcher used comparisons of age, gender, and race to determine rates of death as they
related to frequency of ER visitation and death. A review of the literature reveals both
confirmation and disconfirmation of the current study’s findings, a fact that does not
disqualify the results, but helps to extend the knowledge of the field.
The theoretical premise utilized in the study relates to Andersen’s (2008) model
of health behavior. I addressed this theory using demographic statistics concerning
Medicare and Medicaid patients with CHF and COPD as they relate to age, race, and
gender, by indirectly speaking to the concept of service equality within the context of
perceived need, resource allocation, and predisposing characteristics. Within this context,
need has been proven to be the greatest determinant of health services usage (Andersen,
2008). However, when need is surpassed by concerns about resources or predisposition
characteristics, equality of services can become questionable.
In direct contrast to the findings in this report, a study by O’Neil et al. (2010)
reveals that rates of hospitalization by race for ambulatory care sensitive conditions such
as CHF and COPD differed considerably from those alluded to in the current study.
According to the authors, African Americans with Medicare in Maryland had
significantly higher rates of ACSC hospitalizations for congenital heart failure than any
other race, while Whites had significantly higher rates of hospitalization for COPD
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compared to other races (O’Neil et al., 2010). The current study’s findings differ in that it
lists the rates of frequency of emergency room visits as significantly higher for Whites
than for any other race, though it did not delineate rates for COPD alone, instead
combining it with CHF and presenting the resultant findings as a whole and utilizing data
about ER visitations only.
I used variables, such as age, ER visits, ER claims, payment amounts, gender,
race, and rates of death and disease, to assess utilization and costs of Medicare and
Medicaid beneficiaries identified as having CHF and COPD. The statistics served to
demonstrate Andersen’s (2008) premise that health coverage usage may determine
equality of services. I determined that the variables that contributed to decreased ER
visits of CHF/COPD in the years 2010, 2011, and 2012 related to the supply of PCPs
available during those years. This study’s findings that the year with the lowest ratio of
PCPs per CHF and COPD patients had higher ER rates compared to other years, seems to
coincide with Andersen’ premise that access to services not based on need leads to
inequality of service, and thus the over usage of ER services and financial burden on area
hospitals (Buccaneer, 2011; ccwdata.org). The implications of the study speak to the
impact of access to PCP’s and the possibility that preventative care can positively
contribute to patient health as it relates to ED usage for Medicare and Medicaid
beneficiaries with either COPD or CHF.
Biello et al. (2010) suggested that African Americans were more likely than other
races to be hospitalized for chronic diseases at younger ages, a fact that O’Neil et al.
(2010) attributed to racial disparities in the type and extent of medical services available
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in their communities. The researcher determined that hospitalization at younger ages
could negatively affect the quality of life for the patient due to loss of wages, and risk of
further hospitalizations and severity of illness. The researcher did not look at
hospitalization overall, but focused on ED visitation amongst Medicaid and Medicare
beneficiaries only, as reported by the Administrative Claims Data files in CCW. The
sample size included 100% of the claims data for the years 2010 to 2012, and a 20
percent, or two million, client sample of the Medicare claims as reported by the CCW
during the same period (CCW, 2015).
Because of its focus on ED visitation only, the results differ from the more
broadly scoped studies of hospitalization as a whole. While the researcher in the current
study also concluded that patients under the age of 70 had the highest rates of ER
visitation, (which could coincide with the higher rates of hospitalization for younger
African Americans), it also concluded that Whites had the highest average of ER visits
when compared to other races. Thus, the previous literature both confirms and
disconfirms the study results in this area.
Another area of apparent disagreement between this study and those utilized in
the literature review involves the idea that there is a significant difference in how many
men make more trips to the ER than women. Tsai et al. (2007) and Watson et al. (2004)
found no difference in ER visits by gender, and yet the current study’s findings that men
made more visits to the emergency room at a rate of .01 higher than women, is
contradictory. The results of the current study may extend the previous research due to
the difference in sample size utilized. In a study with a small sample size, the difference
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between a mean of .06 and a mean of .07 may not be as significant, but the extremely
large sample size, (about 2 million prior to subdivision), utilized in this study makes for a
substantial difference, making sample size a confounding variable in this study.
Another phenomenon studied references expenses for ED usage per year. The
findings, that the Medicaid and Medicare payments for ER usage by CHF and COPD
patients was highest in the year with the lowest PCP accessibility, coincides with Aziz et
al. (2011) and Kociol et al.’s (2013) studies on the conditions. These researchers
determined that CHF and COPD represented conditions with the highest admission and
readmission rates, thus the costs to Medicare and Medicaid are significant.
Some factors, not presented as a part of this study, include the rates of
hospitalization and rehospitalization and its relation to the death of Maryland Medicare
and Medicaid beneficiaries with CHF and or COPD. Although much of the literature
reviewed detailed the rates of hospitalization for the aforementioned population, a study
of death rates for this particular group is not included. The current study results indicated
the rates of death for this population, based on findings using data from a sample size of
up to 2 million Medicare and Medicaid beneficiaries, but did not address a possible
correlation between the two ideas.
A recommendation for future research applies to the findings in this study that
look at the relationship between primary care providers and frequency of ED usage. The
inclusion of demographic data relative to PCPs and ER usage, paired with hospitalization,
rehospitalization, and death statistics could present a clear picture of the disparities
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alluded to by Andersen (2008), the primary theoretical framework of this study, and
could extend the previous research considerably.
The current study results align with the methodology of the research in the field,
as claimant information for Medicaid and Medicare beneficiaries is accessible. Other
studies also observed data related to racial disparities, chronic disease trends, and costs of
care on the Medicaid and Medicare population.
Limitations of the Study
The study’s design and implementation has inherent limitations. The most
prominent limitation is within the design of the study. Because the researcher used an
observational retrospective cross-study design with a large sample population, the
question of external validity is considered. The researcher was limited in the use of PCPs
as alternative care groups such as Physician’s Assistants, Nurse Practitioners, and family
doctors were not included in this study. In addition, the types of data that the researcher
could measure and compare due to reliance on Administrative Claims Data from CCW
was an issue. Although the data used in the study produced valuable information about
Medicare and Medicaid beneficiaries’ primary care physician status in Maryland, it did
not differentiate ER usage rates by state, by socioeconomic status, or by hospital, thereby
leaving a gap in an important research area that could have been useful to extend the
research. Thus, the data, while useful as a whole, does not necessarily provide Maryland
hospital administration and lawmakers with the types of generalized information needed
to understand and rectify the inequalities present in their care models.
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Recommendations
The limitations of the study reveal a possible area of potential for future
researchers. To extend the research, there is a need for additional studies designed to
isolate the independent variables relative to geography, patient income, and hospital
spending as it relates to re-hospitalization and death. Further research is needed to include
alternative sources of care such as Physician’s Assistants, Nurse Practitioners and family
doctors in addition to elucidate the relationships between variables. Low-income patients
for example, may be less willing to seek medical treatment regularly due to the costs
associated with doctor’s appointments and or prescription purchasing, a decision that
could negatively influence ED spending as chronic illnesses are worsened and acute care
is needed. Geography’s impact on ER spending could also be important in that
geographic areas in Maryland, like all states, likely contain geographic areas populated
based on income and access to services, thus creating an overuse of ED services, which
in turn raises costs and affects service quality.
In the future, researchers could use a mixed research methodology for a case
study, rather than relying solely on data taken from Administrative Claims Data in CCW.
A mixed research model could offer insights into individual patients’ reasoning behind
using emergency room services rather than taking actions, such as healthy lifestyle or
primary care services, that may have prevented their chronic condition from worsening.
The combination of in depth case studies relative to Maryland ED usage and quantitative
data could be a powerful way to bridge the gap and put a more human face on the data.
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A study of the effects of age, race, gender, and cost on the consistency and quality
of treatment for chronic health conditions could bring to light many of the concepts and
correlational characteristics mentioned in the literature review with reference to the
epidemiological triad model of person, time and place (Anderson, 2008). Future research
could indicate how variables such as the financial burden, on families, hospitals and the
state of Maryland, influence the treatment of CHF and COPD, and spur the development
of preventive measures designed to curb health care costs among Medicare and Medicaid
beneficiaries, while optimizing health.
Implications
The study findings have the potential for real positive change; however, the
limitations of the study may limit its impact. The study problem, combined with the
available research indicates that more research is needed to determine the scope of the
problem as it relates to geographical and racial disparities, and what, if anything, can be
done to eliminate the overcrowding of EDs in Maryland and other states. The findings
correlated to PCP supply and lowered ER costs have the possibility of positively
impacting hospital spending on ED services, as preventative care creates positive change
in the quality of life for ACSC patients. This may be achieved by increasing the supply of
nurse practitioners, physician assistance and family doctors. Furthermore, since ED visits
are not associated with mortality, programs should try to divert patients to less expensive
care sites such as retail medicine, after-hour clinics, and online visits.
The results of the study indirectly support the theoretical framework of the
epidemiological triad through the statistical acknowledgement of the relationships
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specifically between behavior, ecological and environmental factors, and lifestyle and
physical factors and chronic diseases. The implications of the study also positively
correlate to Andersen’s (2008) Model of Health Behavior as it potentially exposes the
predisposing characteristics, enabling resources and need relevant to CHF and COPD
patients. The statistical significance of financial impact, race and age correlates within the
study have the potential of bringing clarity to the theoretical framework, and suggest that
corrections to access to services could result in significant change.
The study results combined with the theoretical framework can guide further
research in determining the optimal PCP supply, and costs analysis of ACSC response to
preventative medicine, which in turn could help researchers to develop a plan to even the
playing field with regard to equality of care. With a projected 127 percent growth in the
number of Americans living with chronic illnesses by the year 2020, the vast majority of
those individuals will be living under the poverty line (Bodenheimer, Chen, & Bennett,
2009). Insight into racial, socioeconomic, and geographical disparities could yield
research that promotes positive social change. However, a limitation of the current study
is that its data does not necessarily coincide with other studies in that the findings did not
show the racial, socioeconomic or geographical disparities highlighted in much of the
literature. Policy makers can utilize the information obtained in this and future studies to
understand the impact of age, gender, and race on supply of PCPs on Medicare and
Medicaid patients, and their impact on hospital ED spending. Hence, this research has the
potential to inform health care delivery system and also improve existing and emerging
public health programs through better care, better health and reduced cost to health care.
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Conclusion
I used a quantitative, observational, and retrospective cross-study design to
answer the following research questions: Is the primary care provider (PCP) supply in a
state associated with frequent ED use among Maryland Medicare and Medicaid
beneficiaries who have CHF or COPD? Is frequent ED use associated with end of life for
Maryland Medicare and Medicaid beneficiaries with either CHF or COPD who die
during the study? The prevalence of Medicare and Medicaid beneficiary utilization of
emergency room services are in direct correlation with the amount of PCPs that are
accessible. Therefore, the answers to these questions could help the state of Maryland to
develop new programs and adjust current practices related to the rising costs of
emergency room care relative to overuse, and simultaneously improve health outcomes or
patients with chronic disorders.
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Appendix A
Summaries of the Literature: Impact of Medicare and Medicaid Beneficiaries with Selected Conditions on Emergency
Department Utilization

Author &
Year
O’Neil S.
O’Neil,
Timothy Lake,
Angela Merrill,
Ander Wilson,
David A.
Mann, Linda
M. Bartnyska
(2010)

Title

Study Design

Racial
Disparities in
Hospitalizations
for Ambulatory
Care–Sensitive
Conditions

Retrospective
study.
A Poisson
regression
model
identified race,
age, gender,
and income as
factors
associated with
differences in
ACSC
hospitalization
rates.

Study
Population
Using 2006
Medicare
claims data,
eight ACSC
hospitalization
measures were
developed for
569,896
Maryland
Medicare
beneficiaries.

Independent
Variables
Race, Age, Gender,
and Income.

Dependent
variables
ACSC,
hospitalization
rates, inhospital
mortality, cost
of care

Results

Other

African
Americans with
Medicare in
Maryland had
significantly
higher unadjusted
rate of ACSC
hospitalizations
related to CHF,
dehydration,
diabetes, adult
asthma, and
hydration than
Whites. Although
African
Americans had a
slightly higher
rate for UTI, the
difference was not
significant.
Whites had
significantly

Race may be a
key predictor of
preventable
emergency
department visits
and
hospitalizations
for some ACSCs.
Racial disparities
in these
hospitalizations
represent excess
costs to
Medicare.Because
ACSC admission
are potentially
preventable,
improving care
for minority may
reduce disparities
and lower hospital
costs.
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Katie Brooks
Biello, James
Rawlings, Amy
Carroll-Scott,
Rosa Browne,
Jeannette R.
Ickovics
(2010).

Racial
Disparities in
Age at
Preventable
Hospitalization
Among U.S.
Adults

Retrospective
study.

Differences in
mean age at
hospital for
ACSCs were
evaluated in a
nationally
representative
sample of 6815
hospital
discharge using
2005 National
Hospital
Discharge
Survey. Linear
regression was
used to
evaluate
differences
among nine
chronic and
three acute
conditions.

Race, Gender,
socioeconomic
status.

Rate of ER
visit and
hospitalization,
Cost of
medical care.

higher rates for
two conditions
(COPD and
bacterial
pneumonia).
Excess costs from
disparities in
quality ranged
from $8 million
(heart failure) to
$38,000 (Urinary
tract infection).
After adjustment
for
sociodemographic
characteristics,
Blacks were
hospitalized ≥5
years earlier than
Whites across all
conditions
combined and for
chronic and acute
conditions
separately. The
largest differences
were seen for
uncontrolled
diabetes (adjusted
difference= −12.0
years) and
bacterial
pneumonia
(adjusted
difference= −7.5
years).

Promoting equity
in disease
prevention,
management, and
treatment should
be a priority of
any healthcare
reform efforts.
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Ellen
Kramarow,
James Lubitz,
Robert Francis
(2012).

Trends in the
Coronary heart
disease risk
profile of
middle-aged
adults

Retrospective
study using
data from the
National
Health and
Nutrition
Examination
Survey from 2
time periods.

1862 (19881994) and 1563
(2005-2008)
from the
NHANES

Gender, Race, and
Age group (45-54
and 55-64).

Coronary
Heart Disease
risk, blood
pressure levels,
total and highdensity
lipoprotein
serum
cholesterol,
weight (BMI),
diabetes, and
smoking
status.

Karen E. Joynt,
E. John Orav,
and Ashish K.
(2015).

The Association
Between
Hospital
Volume and
Processes,
Outcomes, and
Costs of Care
for Congestive
Heart Failure

Retrospective
cohort study.

National
Medicare
claims data
with a primary
discharge
diagnosis of
CHF from
4095 hospitals
in the United
States.

Race, Gender,
socioeconomic
factors.

Mortality rate,
readmission
rate, and cost
per discharge.

The CHD risk
profile of middleaged adults has
improved over
time. For
instance, the mean
10-year risk of
heart attack or
CHD death
among persons 55
to 64 years has
declined from
7.1% to 5.2%.
Declines are seen
among both men
and women and
among nonHispanic Blacks
and non-Hispanic
Whites.
Hospitals in the
low income group
had lower
performance on
the process
measures (80.2%)
than the mediumvolume (87.0%)
or high-volume
(89.1%) hospitals
(P < 0.001). In the
low-volume
group, being
admitted to a
hospital with a
higher case

Despite increase
in diabetes and
obesity, the CHD
risk profile of
middle-aged
adults improved
during the period
from 1988-1994
to 2005-2008.

Experience
managing CHF is
associated with
higher quality of
care and better
outcomes for
patients but a
higher cost.
Understanding
this will help
improve care and
health outcomes
for all CHF
patients.
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Margaret K.
Pasquale,
Shawn X. Sun,
Frank Song,
Heather J.
Hartnett,
Stephen A.
Stemkowski
(2012)

Impact of
Exacerbations
on Health care
cost and
resource
utilization in
chronic
obstructive
pulmonary
disease patients
with chronic
bronchitis from
a predominantly
Medicare
population

A retrospective
analysis which
involves
patients who
were aged 4089 years, had
been enrolled
continuously
for 24 months
or more, who
had at least two
separate
insurance
claims for
COPD with
chronic
bronchitis.

Retrospective
analysis was
performed on
data extracted
from a large
national health
plan with a
predominantly
Medicare
population –
involves 8554
patients from
2007-2009.

Age, Gender,
Race/Ethnicity,
United States
geographic region
(Midwest,Northeast,
South, West),
Income level.

DCI Score,
Top five
comorbidities
[n (%)] –
Congestive
heart failure,
Related COPD
diagnoses,
Diabetes
without
complication,
Peripheral
vascular
disease, renal
disease,
Maintenance
medication
total [n (%)].

volume was
associated with
lower mortality,
lower
readmission, and
higher costs.
Similar, though
smaller,
relationships were
found between
case volume and
both mortality and
costs in the
medium-and highvolume hospital
groups.
Generalized linear
regression model
was computed
using SPSS. Pvalues < 0.05 was
considered to
indicate
statistically
significant
differences. GLM
with log link and
gamma
distribution for
the term, was
used to estimate
adjusted health
care costs –
controlling for
demographic and
clinical

The results
indicated that
despite treatment
with maintenance
medications,
COPD patients
continue to have
exacerbations
resulting in higher
costs. New
medication and
disease
management
intervention is
needed to severity
and frequency of
exacerbations and
related cost
impact of the
disease.
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characteristics.
49.8% of the
overall population
had exacerbation,
13.9% had a
severe
exacerbation only,
29.1% had a
moderate
exacerbation only,
and 6.8% had a
severe and
moderate
exacerbation.
COPD-related
mean annual costs
were $4069 for
overall population
and $6381 for
patients two or
more
exacerbations.
All-caused health
care costs were
$18,976 for the
overall population
and $23,901 for
patients with
history of two or
more
exacerbations.
Severity of
exacerbation,
presence of
cardiovascular
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Anand A.
Dalal, Manan
Shah, Anna O.
D’Souza,
Pallavi Rane
(2010).

Cost of COPD
exacerbations in
the emergency
department and
inpatient setting

A
retrospective,
cross-sectional
study of
healthcare
costs and
utilization
using hospital
administrative
data from the
Premier
Perspective
Database. The
study evaluated
outcomes of
Medicare
Population for
three categories
of utilization:
ED visits,
simple
inpatient
admissions,
and complex
inpatient
admissions.

Administrative
data from 602
hospitals were
used to
calculate 2008
costs for
COPD-related
emergency
department
visits, simple
inpatient
admissions and
admissions
among COPD
patients aged >
40 years.

Age, Gender, Payor
(Medicare,
Medicaid,
Commercial selfpay, and other,
Geographic region
(East, Midwest,
South, West).

ED visits,
Inpatient
mortality rate,
length of stay,
and
readmission
rates in 20052008, and
COPD
conditions
were
calculated.

disease, diabetes,
and long-term,
oxygen use were
associated with
higher adjusted
costs.
Statistical
analyses were
conducted using
SPSS (v.9.1.3).
The database
contained deidentified billing
and coding data
and patient
demographic and
hospital
characteristics
from 602 not for
profit hospitals. A
total of 71,493
encounters met
inclusion criteria.
Of these, 28.7%
were ED visits,
49.*% were
simple inpatient
admission s, and
4.8% were
complex inpatient
admissions. More
than half of ED
visits and
inpatient
admissions
occurred in

Costs of hospitalbased care for
COPD are
substantial.
Admissions
involving
intubation or
intensive care are
associate with the
highest costs and
mortality.

111
females (56.4%)
and patients who
were 65 years of
age or older.
Mean 2008 costs
were $647 for ED
visits, $7242 for
simple
admissions, and
$20,757 for
complex
admissions.
Intensive
care/intubation
admissions
incurred the
highest costs
$44,909. Complex
admission
accounted for
5.8% of hospitalbased COPD care
in 2008 but 20.9%
of costs.

Marco daCosta
DiBonaventura,
Ryne PauloseRam, Jun Su,
Margaret
McDonald,
Kelly H Zou,
Jan-Samuel
Wagner, Hemal
Shah (2012).

The burden of
chronic
obstructive
pulmonary
disease among
employed
adults

A crosssectional study
from a selfadministered,
internet-based
questionnaire
from a sample
population
identified
through a web-

Data were
obtained from
75,000
respondents
who completed
the 2009 US
National
Health and
Wellness
Survey

Age, Gender,
Race/ethnicity,
education level,
household income,
health insurance and
type of employment
(FT/PT, SE), BMI.

Health
condition
(COPD),
Health utility
score, ER
visits, mental
component,
physical
component
summaries.

After adjusting
for demographics
and patient
characteristics,
adults with COPD
reported
significantly
lower mean level
of the various
components than

Employed adults
with COPD
reported
significantly
lower quality of
life and work
productivity, and
increased health
resource
utilization than
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Karin B.
Yeatts, Steven

PopulationBased Burden

based
consumer
panel.

(NHWS). The
study focused
on 40 years or
older.

Populationbased

Using SPSS
(v.9.2) to run

Age, Gender,
insurance type

ED visits,
hospital

adults without
COPD. Overall
work impairment
(20.5% vs
16.3%), and
impairment in
daily activities
(23.5% vs 17.9%)
than adults
without COPD.
Employed adults
with COPD also
reported more
mean emergency
room visits (0.21
vs 0.12) and more
mean
hospitalizations
(0.10 vs 0.06) in
the previous
months than
employed adults
without COPD.
All of the
differences were
significantly at
two-sided P <
0.05. The results
depicts the
substantial impact
and burden of
COPD in the
United States
workforce.
In 2008 to 2009 in
North Carolina,

employed adults
without COPD.

Population-based
burden of COPD-
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J. Lippmann,
Anna E.
Walker, Kristen
Hassmiller
Lich, Debbie
Travers, Morris
Weinberger,
James F.
Donohue
(2013).

of COPDRelated Visits
in the ED
Return ED
visits, Hospital
Admissions,
and
Comorbidity
Risks.

retrospective
cohort design
was used to
identify all
patients 45
years or older
who had at
least one
COPD related
Ed visit
between 2008
and 2009.

generalized
linear models,
97,511 COPD
related patients
were examined
in North
Carolina from
110 and 111
eligible
hospitals in
2008 and 2009
respectively.

(Medicare,
Medicaid, Private,
other gov’t), Time

discharge rate,
hospital
admission rate,
most common
conditions –
hypertension,
respiratory
failure/
shortness of
breath, heart
disease,
tobacco use,
diabetes,
congestive
heart failure.

97,511 COPDrelated ED visits
were made by
adults 45 years or
older at an annual
rate of 13.8% ED
visits/1,000
person. Among
Patients with
COPD (n-33,977),
7% and 28% had
a COPD-related
return ED visits
within a 30 and
365 day period of
their index visit
respectively.
Fifty-one percent
of patients with
COPD were
admitted to the
hospital from the
index ED visit.
Hospital
admission
increased with
age in the cohort.
Patients with
congestive heart
failure were more
likely to have
subsequent
hospital
admission
compared with
patients without

related care in the
ED is significant.
Further studies is
needed to
understand
variations in
COPD-related ED
visits and hospital
admissions.
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Christopher M.
Blanchette,
Nicholas J.
Gross, Pablo
Altman (2014).

Rising Costs of
COPD and the
Potential for
Maintenance
Therapy to slow
the Trend

Longitudinal
studies of the
costs
associated with
the
management of
patients with
COP, the costs
associated with
hospitalizations
for acute
exacerbation of
COPD, and
randomized
clinical trials
evaluating
effects of
maintenance
therapy of
COPD.

62 studies from
28 countries for
adults who
have COPDrelated
conditions.

Age, Gender,
insurance type, 28
Countries

ED visits,
Health
utilization,
COPD-related
conditions
(smoking,
coronary heart
disease
hypertension,
stroke asthma,
diabetes,
myocardial
infraction.

these conditions.
A meta-analysis
that included 62
studies from 28
countries reported
that prevalence of
COPD among
smokers was
15.4% compared
with 10.7%
among
nonsmokers. The
study found that
smoking was
responsible for
more than 77% of
all deaths from
COPD in US.
The direct
healthcare costs
for patients with
COPD increased
by 38% between
1987 – 2007, and
continued to
increase by 5%
annually between
2006 – 2009. The
costs associated
with hospital
admissions for
patients with
COPD accounted
for the largest
increase $2,289

The study
suggested that
treatment of acute
exacerbation of
COPD remains
the major driver
of increasing
healthcare costs
associate with the
condition.
Appropriate use
of maintenance
therapy has been
shown to reduce
the incidence of
exacerbations and
has the potential
to reduce overall
costs.
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Perera N.
Prasdini,
Edward P.
Amstrong,
Duane L.
Sherrill, Grant
H. Skrepnek
(2012)

Acute
Exacerbations
of COPD in the
United States:
Inpatient
Burden and
Predictors of
Costs and
Mortality

Analysis of the
Healthcare cost
and utilization
project data.
This study
determined the
national
inpatient
burden of
AECOPD and
assessed the
association of
co-morbidities
and hospital
characteristics
with inpatient
costs and
mortality.

1,254,703
hospitalizations
for AECOPD
were observed
in the United
States.

Age, Gender,
Insurance,
geographic region,
Weight (BMI)

ED visits,
COPD-related
conditions,
length of stay,
admission
period.

per admission in
2007. Recent
estimate suggest
that the aggregate
costs associated
with treatment
was between $3.2
billion and 3.8
billion, and
annual healthcare
costs were 10-fold
greater for
patients with
COPD associated
with acute
exacerbation.
From 2006 –
2010, the
aggregate cost for
hospitalization for
acute COPD
exacerbation
increased from
$2.96 billion to
$3.47 billion.
Overall,
1,254,703
hospitalizations
for AECOPD
were observed
with mean costs
of
$9545(±12,700)
and total costs of
$11.9 billion. Inhospital mortality

Future research
should determine
if better
management of
these conditions
can favorably
impact the COPD
disease burden.
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Yu, A. P.,
Yang, H., Wu,
E. Q.,
Setyawan, J.,
Mocarski, M.,
& Blum, S
(2011).

Incremental
third-party costs
associated with
COPD
exacerbations: a
retrospective
claims analysis

Analysis of
service claims
and costs data
from the
Thomson
Reuters
MarketScan
database. The
method used
for defining
exacerbations
does not

A total of
2644,174
patientquarters,
derived from
228,978 COPD
patients in the
United States
were included
in the analysis.
The average
patient was

Age, Gender,
Insurance,
Geographic region

ED visits,
COPD-related
conditions,

was 4.3% (N =
53,748).
Discharges
averaged 70.6
(±11.9) years of
age. The majority
were female
(52.8%) and of
White race
(83.6% of
reported race).
Several comorbidities were
significantly
associated with
both costs and
mortality (p <
0.001.
Significantly
higher costs (p <
0.001) were
associated with
large and urban
hospitals.
In 2004-2008, the
total COPDrelated cost for
patients with a
severe
exacerbation was
$7014 per quarter.
Cost associated
with COPD
patients who had
no exacerbations
was $658 per

Exacerbations,
especially severe
ones, result in a
significant
economic burden
for third-party
payers. Effective
management of
COPD and
prevention of
exacerbations
may lead to
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capture mild
exacerbations.
Additional
limitations
exist due to the
nature of
claims data.

followed an
average of 2.9
years.

quarter or $2632
annually. The
mean total cost
was $17,016 per
patient-quarter
with severe
exacerbation,
$6628 per patientquarter with nonsevere
exacerbation, an
average of $8726
per patientquarters with any
exacerbation
compared to
$4762 per patientquarter with no
exacerbation.
After adjusting
for patient
demographics, the
mean incremental
total cost was
$11,261 per
patient-quarter
with severe
exacerbation,
$1509 per patientquarter for nonsevere
exacerbation, and
$3439 per patientquarter with any
exacerbation

improved patient
outcomes and
reduction in total
healthcare costs
for long-term
management of
COPD.
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compared with
patient-quarters
with no
exacerbation.

Dalal, A. A.,
Shah, M.,
Lunacsek, O.,
& Hanania, N.
A. (2011).

Clinical and
economic
burden of
patients
diagnosed with
COPD with
comorbid
cardiovascular
disease

A retrospective
cohort study of
COPD
patients CVD
± ≥40 years of
age using
administrative
claims data
were
conducted.
COPD-CVD
patients were
matched to
COPD patients
without CVD
(COPD-Only
cohort) using
propensity
scores

Each cohort
included 4594
patients with
COPD-related
conditions in
the United
States.
Multivariate
analyses were
conducted to
assess the 1year risk of
COPD
exacerbations
(hospitalization
and or
emergency
room visits),
along with
differences in
1-year and 2year all-cause
and COPDrelated
utilization and
costs among
COPD-CVD
and COPDOnly cohorts.

Age, Gender,
Insurance Type
(Commercial or
Medicare
Advantage),

ED visits,
COPD-related
conditions,
simple
inpatient
admission,

Compared to
COPD-Only
cohort, the
COPD-CVD
cohort was almost
2 times more
likely to require
COPD-related
hospitalization
(odds ratio [OR],
1.95; p < 0.001),
47% more likely
to have an ER
visit (OR, 1.47;
p < 0.001) and
62% more likely
to require
hospitalization
and or ER visit
(OR, 1.62;
p < 0.001).
Average annual
all-cause medical
costs per patient
were $22,755 for
COPD-CVD vs
$8036 for COPDOnly (p < 0.001),
and total costs
were $27,032 vs

COPD patients
with CVD have
significantly
higher risk of
COPD
exacerbations and
increased costs
than COPD
patients without
CVD. This
suggests a close
association
between COPD
and CVD that
needs further
exploration.
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$11,506
(p < 0.001),
respectively;
corresponding
average COPDrelated annual
medical costs
were $1891 vs
$1060 (p < 0.001)
and total costs
were $3295 vs
$2379
(p < 0.001).

Summary of the Literature: Impact of Medicare and Medicaid Beneficiaries with Selected Conditions on Emergency Department
Utilization
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Appendix B
CHF and COPD Codes
CHF Codes used in this study were: 39891, 40201, 40211, 40291, 40401, 40403, 40491,
40493, 4280, 4281, 42820, 42821, 42822, 42823, 42830, 42831, 42832, 42833, 42840,
42841, 42842, 42943, 4289.
COPD Codes used in this study were: 490, 4910, 4911, 4918, 4919, 4920, 4928, 49120,
49121, 49122, 4940, 4941, 496.
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Appendix C
Primary Care Physician Codes Used in This Study

Code

Description

01

General Practice

08

Family Practice

11

Medicine

38

Geriatric Medicine

